| 1 | - Skin biopsy - Urine sample - Blood sample | - | - | - | - | [1] 51 51 💬
|
| 2 | 0,5 mg Prevenar i.m. | - | - | - | - | [1] 51 51 💬
|
| 3 | 0,5 mg seasonal influenza vaccine i.m. | - | - | - | - | [1] 51 51 💬
|
| 4 | 0.9% sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [5] 6 6, 14, 51, 53, 96 💬
|
| 5 | 1 infusion of MSC | - | - | - | - | [1] 51 51 💬
|
| 6 | 1-(6-BENZOTHIAZOLYLSULFONYL)-5-CHLORO-1H-INDOLE-2-BUTANOIC ACID | [1] Indole Indole | - | - | - | [1] 51 51 💬
|
| 7 | 1-22460 | - | - | - | - | [1] 51 51 💬
|
| 8 | 10 mg/kg CM-101 | [1] CM-101 CM-101 | - | - | - | [1] 51 51 💬
|
| 9 | 10% Nitroglycerine in Propylene Glycol, USP | [1] Propylene glycol Propylene glycol | [2] Propylene glycol
Propylene glycol
,
Propylene glycol diacetate
💬
| - | - | [1] 51 51 💬
|
| 10 | 10% urea lotion plus 1% cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [1] 51 51 💬
|
| 11 | 2 infusions of MSC | - | - | - | - | [1] 51 51 💬
|
| 12 | 2-(((2E)-3-(3-methoxy-4-(2-propyn-1-yloxy)phenyl)-1-oxo-2-propen-1-yl)amino)benzoic acid | [1] Benzoic acid Benzoic acid | [2] Benzoic acid
Benzoic acid
,
Sodium benzoate
💬
| - | - | [1] 51 51 💬
|
| 13 | 3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt | - | - | - | - | [2] 51 51, 85 💬
|
| 14 | [89Zr]Zr-Df-crefmirlimab berdoxam | [1] Crefmirlimab Crefmirlimab | - | - | - | [2] 51 51, 53 💬
|
| 15 | [ACE-1334] | - | - | - | - | [1] 51 51 💬
|
| 16 | [BIBF 1120] | - | - | - | - | [1] 51 51 💬
|
| 17 | [G451990] | - | - | - | - | [2] 51 51, 85 💬
|
| 18 | [HZN-825] | - | - | - | - | [1] 51 51 💬
|
| 19 | [IgPro10] | - | - | - | - | [1] 51 51 💬
|
| 20 | [IgPro20] | - | - | - | - | [2] 50 50, 51 💬
|
| 21 | [JBT-101] | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 💬
|
| 22 | [L01AA01] | - | - | - | - | [1] 51 51 💬
|
| 23 | [L03AA02] | - | - | - | - | [1] 51 51 💬
|
| 24 | [L04AA04] | - | - | - | - | [1] 51 51 💬
|
| 25 | [L04AA06] | - | - | - | - | [1] 51 51 💬
|
| 26 | [MT-7117] | - | - | - | - | [2] 51 51, 254 💬
|
| 27 | [N/A] | - | - | - | - | [11] 2 2, 11, 13, 20, 28, 46, 51, 61, 65, 97, 299 💬
|
| 28 | [PRA023] | - | - | - | - | [2] 51 51, 97 💬
|
| 29 | [RO487-7533/F10-04] | - | - | - | - | [1] 51 51 💬
|
| 30 | A novel synthetic, orally-administered, non-peptide small molecule, which acts as an agonist of the melanocortin-1 receptor (MC1R) | - | - | - | - | [1] 51 51 💬
|
| 31 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [14] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Graft-versus-host disease, IgSF CAM signaling, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [28] 2 2, 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 223, 271, 284, 285, 300 💬
|
| 32 | Abituzumab | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 33 | Abituzumab 1500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 34 | Abituzumab 500 mg | [1] Abituzumab Abituzumab | - | - | - | [1] 51 51 💬
|
| 35 | ABR-215757 | - | - | - | - | [2] 49 49, 51 💬
|
| 36 | Acetaminophen | [1] Acetaminophen Acetaminophen | [1] Acetaminophen
Acetaminophen
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [19] 11 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
|
| 37 | Acetate | [1] Acetate Acetate | - | - | - | [52] 1 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
|
| 38 | Acetylcysteine | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [25] 2 2, 6, 13, 19, 20, 21, 34, 49, 51, 53, 58, 63, 85, 90, 94, 97, 111, 164, 193, 233, 296, 298, 299, 303, 337 💬
|
| 39 | ACETYLSALICYLIC ACID | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [5] 13 13, 46, 51, 62, 210 💬
|
| 40 | ACHIM | - | - | - | - | [1] 51 51 💬
|
| 41 | ACHIM as solute (10^9 intestinal microbes/ml) | - | - | - | - | [1] 51 51 💬
|
| 42 | ACHIM capsules | - | - | - | - | [1] 51 51 💬
|
| 43 | Acido Micofenolico | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [2] 49 49, 51 💬
|
| 44 | Acotiamide | [1] Acotiamide Acotiamide | - | - | - | [2] 11 11, 51 💬
|
| 45 | ACT-064992 | - | - | - | - | [5] 51 51, 85, 86, 88, 210 💬
|
| 46 | ACT-293987 | - | - | - | - | [3] 51 51, 86, 88 💬
|
| 47 | Ad26.COV2.S | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 48 | Adempas | - | - | - | - | [5] 51 51, 86, 88, 225, 299 💬
|
| 49 | ADEMPAS - 1 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 50 | ADEMPAS - 1,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 51 | ADEMPAS - 2 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 52 | ADEMPAS - 2,5 MG - COMPRESSA RIVESTITA CON FILM - USO ORALE - BLISTER (PP/ALU) - 42 COMPRESSE | - | - | - | - | [2] 51 51, 86 💬
|
| 53 | ADI-001 | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 54 | Administration of rituximab and methylprednisolone | [2] Methylprednisolone Methylprednisolone, Rituximab | [3] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
,
Rituximab
💬
| [2] MS4A1 MS4A1, NR3C1 💬
| [2] Hematopoietic cell lineage Hematopoietic cell lineage, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 55 | AdMSC | - | - | - | - | [1] 51 51 💬
|
| 56 | ADSVF application in the right hand | - | - | - | - | [1] 51 51 💬
|
| 57 | AIMSPRO | - | - | - | - | [2] 13 13, 51 💬
|
| 58 | Albumin | - | - | - | - | [3] 2 2, 20, 51 💬
|
| 59 | ALEMTUZUMAB | [1] Alemtuzumab Alemtuzumab | [1] Alemtuzumab
Alemtuzumab
💬
| - | - | [21] 13 13, 14, 15, 19, 20, 36, 43, 44, 46, 51, 60, 63, 65, 85, 96, 107, 164, 283, 284, 285, 326 💬
|
| 60 | Alginic acid | [1] Alginic acid Alginic acid | [2] Alginic acid
Alginic acid
,
Sodium alginate
💬
| - | - | [1] 51 51 💬
|
| 61 | Allogeneic CD19/BCMA-targeted CAR-?dT cell injection | - | - | - | - | [2] 49 49, 51 💬
|
| 62 | Allogeneic hematopoietic stem cell transplantation | - | - | - | - | [8] 28 28, 51, 60, 62, 65, 164, 284, 285 💬
|
| 63 | Allogeneic Mesenchymal Stem Cells (AlloMSC) | - | - | - | - | [2] 51 51, 53 💬
|
| 64 | Allogeneic NK Cells | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 65 | AlloRx | - | - | - | - | [8] 2 2, 13, 46, 51, 85, 90, 97, 226 💬
|
| 66 | Alpha-2C AR antagonist | - | - | - | - | [1] 51 51 💬
|
| 67 | Alprostadil | [1] Alprostadil Alprostadil | [1] Alprostadil
Alprostadil
💬
| [1] PTGER1 PTGER1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Human cytomegalovirus infection, Neuroactive ligand-receptor interaction, Pathways in cancer 💬 | [2] 51 51, 70 💬
|
| 68 | AM-01 | - | - | - | - | [1] 51 51 💬
|
| 69 | Ambrisentan | [1] Ambrisentan Ambrisentan | [1] Ambrisentan
Ambrisentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [10] 51 51, 66, 84, 85, 86, 88, 210, 211, 218, 222 💬
|
| 70 | Amlitelimab | [1] Amlitelimab Amlitelimab | [1] Amlitelimab
Amlitelimab
💬
| [1] TNFSF4 TNFSF4 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 51 51 💬
|
| 71 | Amlodipine | [1] Amlodipine Amlodipine | [4] Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 51 51, 67, 79, 113, 222, 298 💬
|
| 72 | Amlodipine Gel | [1] Amlodipine Amlodipine | [4] Amlodipine besylate
Amlodipine besylate
,
Amlodipine maleate
,
Amlodipine
,
Amlodipine benzoate
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 73 | Anaerobically Cultivated Human Intestinal Microbiota | - | - | - | - | [1] 51 51 💬
|
| 74 | Anaerobically Cultivated medium | - | - | - | - | [1] 51 51 💬
|
| 75 | ANIFROLUMAB | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [6] 46 46, 48, 49, 50, 51, 53 💬
|
| 76 | Anti Thymocyte Globulin | - | - | - | - | [1] 51 51 💬
|
| 77 | Anti-CD19 CAR T cell therapy | - | - | - | - | [5] 48 48, 49, 50, 51, 53 💬
|
| 78 | Anti-CD19 CAR-T cells | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [6] 46 46, 49, 50, 51, 53, 222 💬
|
| 79 | Anti-CD19 IL-10/IL15 CAR-NK | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 80 | Anti-CD19-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 81 | Anti-CD19-CD3E-CAR-T cells | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 82 | Anti-CD19/BCMA U CAR T cells | - | - | - | - | [4] 46 46, 49, 51, 53 💬
|
| 83 | Anti-CD19/BCMA-UCAR-T cells | - | - | - | - | [4] 46 46, 49, 50, 51 💬
|
| 84 | Anti-CT51 antigen mAb | - | - | - | - | [1] 51 51 💬
|
| 85 | ANTI-HUMAN T-LYMPHOCYTE IMMUNOGLOBULIN FROM RABBITS | - | - | - | - | [1] 51 51 💬
|
| 86 | Anti-integrin alphaV mAb | - | - | - | - | [1] 51 51 💬
|
| 87 | Anti-pandemic H1N1 influenza vaccine | - | - | - | - | [7] 46 46, 48, 49, 50, 51, 53, 107 💬
|
| 88 | Anti-Thymocyte Globulin | - | - | - | - | [19] 11 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 63, 65, 164, 283, 284, 285 💬
|
| 89 | Anti-Thymocyte Globulin, Rabbit | [1] Rabbit Rabbit | - | - | - | [1] 51 51 💬
|
| 90 | Antifibrotic drugs (nidanib or pirfenidone) | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 💬
|
| 91 | AP01 | - | - | - | - | [3] 46 46, 51, 85 💬
|
| 92 | ASASANTIN Retard | - | - | - | - | [1] 51 51 💬
|
| 93 | Asasantin Retard ® | - | - | - | - | [1] 51 51 💬
|
| 94 | Aspirin | [1] Acetylsalicylic acid Acetylsalicylic acid | [1] Aspirin
Aspirin
💬
| [2] PTGS1 PTGS1, PTGS2 💬
| [23] Alzheimer disease Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬 | [10] 22 22, 34, 48, 49, 51, 63, 86, 158, 210, 231 💬
|
| 95 | Assigned Interventions CD19/BCMA CAR T-cells | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 96 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [21] 13 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 222, 225, 265, 271, 297, 299 💬
|
| 97 | AUC of MPA measure | - | - | - | - | [1] 51 51 💬
|
| 98 | Autologous ADRCs injection Combined with Standard Therapy | - | - | - | - | [1] 51 51 💬
|
| 99 | Autologous ASC | - | - | - | - | [1] 51 51 💬
|
| 100 | Autologous CD19-BCMA Dual-Target CAR T-Cell Therapy | - | - | - | - | [5] 13 13, 49, 51, 53, 61 💬
|
| 101 | Autologous Hematopoietic Stem Cell Transplantation | - | - | - | - | [7] 11 11, 13, 14, 28, 49, 51, 84 💬
|
| 102 | Autologous Regulatory ?-cells | - | - | - | - | [1] 51 51 💬
|
| 103 | Autologous Stem Cells | - | - | - | - | [2] 13 13, 51 💬
|
| 104 | Autologous stemcell transplantation with CD (cluster of differentiation) 34 selected stem cells | - | - | - | - | [1] 51 51 💬
|
| 105 | Avenciguat | [1] Avenciguat Avenciguat | [1] Avenciguat
Avenciguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 106 | Avenciguat (BI 685509) | [1] Avenciguat Avenciguat | [1] Avenciguat
Avenciguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 107 | AVID200 | - | - | - | - | [1] 51 51 💬
|
| 108 | Aviptadil | [1] Aviptadil Aviptadil | [1] Aviptadil
Aviptadil
💬
| - | - | [4] 49 49, 51, 84, 86 💬
|
| 109 | AZD0120 | - | - | - | - | [4] 28 28, 46, 49, 51 💬
|
| 110 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [24] 2 2, 13, 40, 41, 46, 49, 50, 51, 53, 54, 56, 63, 65, 84, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
| 111 | Basic treatment | - | - | - | - | [1] 51 51 💬
|
| 112 | BAY63-2521 | - | - | - | - | [3] 51 51, 86, 299 💬
|
| 113 | BCMA-CD19 CAR-T therapy | - | - | - | - | [6] 48 48, 49, 51, 53, 56, 64 💬
|
| 114 | BCMA/CD70-targetd CAR-T | - | - | - | - | [4] 50 50, 51, 53, 107 💬
|
| 115 | BCT301 | - | - | - | - | [3] 48 48, 51, 53 💬
|
| 116 | Behavioral: Questionnaire | - | - | - | - | [3] 46 46, 51, 329 💬
|
| 117 | BELIMUMAB | [1] Belimumab Belimumab | [1] Belimumab
Belimumab
💬
| [1] TNFSF13B TNFSF13B 💬
| [4] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis 💬 | [17] 11 11, 13, 43, 44, 46, 48, 49, 50, 51, 53, 63, 66, 95, 222, 223, 296, 300 💬
|
| 118 | Belumosudil | [1] Belumosudil Belumosudil | [2] Belumosudil
Belumosudil
,
Belumosudil mesylate
💬
| [1] ROCK2 ROCK2 💬
| [23] Adherens junction Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 85, 228 💬
|
| 119 | Belumosudil (KD025) | [1] Belumosudil Belumosudil | [2] Belumosudil
Belumosudil
,
Belumosudil mesylate
💬
| [1] ROCK2 ROCK2 💬
| [23] Adherens junction Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 120 | Bendamustine | [1] Bendamustine Bendamustine | [3] Bendamustine hydrochloride
Bendamustine hydrochloride
,
Bendamustine
,
Bendamustine hydrochloride hydrate
💬
| - | - | [6] 13 13, 28, 49, 50, 51, 61 💬
|
| 121 | Benzoic acid | [1] Benzoic acid Benzoic acid | [2] Benzoic acid
Benzoic acid
,
Sodium benzoate
💬
| - | - | [1] 51 51 💬
|
| 122 | BERMEKIMAB | [1] Bermekimab Bermekimab | [1] Bermekimab
Bermekimab
💬
| [1] IL1A IL1A 💬
| [21] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 51 51 💬
|
| 123 | BH4 | - | - | - | - | [2] 51 51, 240 💬
|
| 124 | BI 1015550 (Nerandomilast) | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 125 | BIBF 1120 | - | - | - | - | [2] 51 51, 85 💬
|
| 126 | Biological: cizutamig | - | - | - | - | [1] 51 51 💬
|
| 127 | Biological: GB261 | - | - | - | - | [1] 51 51 💬
|
| 128 | Biopsy | - | - | - | - | [7] 28 28, 34, 51, 65, 97, 193, 285 💬
|
| 129 | Biospecimen Collection | - | - | - | - | [18] 13 13, 26, 28, 34, 46, 49, 50, 51, 53, 60, 62, 65, 96, 97, 159, 284, 285, 286 💬
|
| 130 | Blood coagulation factor XIII | - | - | - | - | [1] 51 51 💬
|
| 131 | Blood draw | - | - | - | - | [16] 3 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
|
| 132 | Blood sample | - | - | - | - | [33] 2 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
|
| 133 | Blood sample collection | - | - | - | - | [4] 48 48, 51, 85, 111 💬
|
| 134 | Blood samples | - | - | - | - | [14] 13 13, 41, 46, 49, 51, 61, 63, 96, 97, 160, 167, 227, 240, 271 💬
|
| 135 | Blood sampling | - | - | - | - | [15] 2 2, 3, 13, 14, 17, 46, 51, 64, 86, 96, 97, 98, 106, 162, 300 💬
|
| 136 | Blood test | - | - | - | - | [19] 2 2, 6, 13, 36, 46, 49, 51, 74, 79, 83, 96, 113, 127, 162, 227, 256, 280, 299, 300 💬
|
| 137 | Blood test and principal collection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 138 | BMS-986020 | [1] BMS-986020 BMS-986020 | - | - | - | [2] 51 51, 85 💬
|
| 139 | BMS-986353 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 140 | BNT162b2 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 141 | BNT162b2, Bivalent | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 142 | Bone marrow transplantation | - | - | - | - | [4] 51 51, 60, 284, 285 💬
|
| 143 | BORTEZOMIB | [1] Bortezomib Bortezomib | [1] Bortezomib
Bortezomib
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [19] 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 223, 228, 256, 283, 288, 331 💬
|
| 144 | Bosentan | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [12] 13 13, 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬
|
| 145 | Bosentan (Tracleer) | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 146 | Bosentan 125 mg | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 147 | Bosentan 62.5 mg | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 148 | Bosentan group | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 149 | BOSENTAN MONOHYDRATE | [1] Bosentan Bosentan | [2] Bosentan
Bosentan
,
Bosentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 84, 86, 88 💬
|
| 150 | BOTOX® solution | - | - | - | - | [1] 51 51 💬
|
| 151 | Botulinum toxin type B | [1] Botulinum toxin type B Botulinum toxin type B | [1] RimabotulinumtoxinB
RimabotulinumtoxinB
💬
| [1] SNAP25 SNAP25 💬
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [3] 2 2, 6, 51 💬
|
| 152 | Botulinum toxin type B (2500 units / vial) | [1] Botulinum toxin type B Botulinum toxin type B | [1] RimabotulinumtoxinB
RimabotulinumtoxinB
💬
| [1] SNAP25 SNAP25 💬
| [2] Insulin secretion Insulin secretion, Synaptic vesicle cycle 💬 | [1] 51 51 💬
|
| 153 | Botulinum toxin(Botox) | - | - | - | - | [1] 51 51 💬
|
| 154 | Bovine type I collagen | [1] Bovine type I collagen Bovine type I collagen | - | - | - | [1] 51 51 💬
|
| 155 | Brentuximab | [1] Brentuximab Brentuximab | - | - | - | [2] 49 49, 51 💬
|
| 156 | Brentuximab vedotin | [2] Brentuximab Brentuximab, Brentuximab vedotin | [1] Brentuximab vedotin
Brentuximab vedotin
💬
| [10] TNFRSF8 TNFRSF8, TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 💬
| [13] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Cytokine-cytokine receptor interaction, Gap junction, Huntington disease, IgSF CAM signaling, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagocytosis, Prion disease, Salmonella infection 💬 | [2] 49 49, 51 💬
|
| 157 | BRL-301 | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 158 | Brodalumab | [1] Brodalumab Brodalumab | [1] Brodalumab
Brodalumab
💬
| [1] IL17RA IL17RA 💬
| [3] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway 💬 | [2] 37 37, 51 💬
|
| 159 | Bronchoalveolar lavage (BAL fluid) | - | - | - | - | [2] 49 49, 51 💬
|
| 160 | Bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [10] 46 46, 51, 53, 70, 71, 96, 97, 168, 226, 298 💬
|
| 161 | Buspirone | [1] Buspirone Buspirone | [2] Buspirone hydrochloride
Buspirone hydrochloride
,
Buspirone
💬
| [2] DRD2 DRD2, HTR1A 💬
| [12] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, Taste transduction, cAMP signaling pathway 💬 | [3] 6 6, 51, 179 💬
|
| 162 | Busulfan | [1] Busulfan Busulfan | [1] Busulfan
Busulfan
💬
| - | - | [14] 19 19, 20, 28, 34, 36, 49, 51, 60, 65, 164, 274, 284, 285, 326 💬
|
| 163 | C-82 Topical Gel, 1% | - | - | - | - | [1] 51 51 💬
|
| 164 | C21 | - | - | - | - | [2] 51 51, 85 💬
|
| 165 | C225 | - | - | - | - | [2] 51 51, 86 💬
|
| 166 | CABA-201 | - | - | - | - | [5] 11 11, 13, 35, 49, 51 💬
|
| 167 | Cabozantinib | [1] Cabozantinib Cabozantinib | [2] Cabozantinib
Cabozantinib
,
Cabozantinib s-malate
💬
| [3] AXL AXL, KDR, MET 💬
| [28] Adherens junction Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Efferocytosis, Epithelial cell signaling in Helicobacter pylori infection, Fluid shear stress and atherosclerosis, Focal adhesion, Gastric cancer, Hepatocellular carcinoma, IgSF CAM signaling, Integrin signaling, MAPK signaling pathway, Malaria, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, PI3K-Akt signaling pathway, Pathways in cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Renal cell carcinoma, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [9] 13 13, 34, 46, 49, 50, 51, 53, 96, 97 💬
|
| 168 | Calcipotriene | - | - | - | - | [1] 51 51 💬
|
| 169 | Calcium | [1] Calcium Calcium | - | - | - | [39] 2 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
|
| 170 | Calcium Channel Blockers | [1] Calcium Calcium | - | - | - | [1] 51 51 💬
|
| 171 | CAM2043 | - | - | - | - | [1] 51 51 💬
|
| 172 | Campath | - | - | - | - | [3] 49 49, 51, 60 💬
|
| 173 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] Cannabidiol
Cannabidiol
💬
| [2] CNR1 CNR1, CNR2 💬
| [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [20] 6 6, 8, 13, 19, 36, 46, 51, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 💬
|
| 174 | CAPILLAREMA | - | - | - | - | [1] 51 51 💬
|
| 175 | CAR-T Therapy | - | - | - | - | [2] 49 49, 51 💬
|
| 176 | Carbon dioxide | [1] Carbon dioxide Carbon dioxide | [1] Carbon dioxide
Carbon dioxide
💬
| - | - | [4] 50 50, 51, 97, 158 💬
|
| 177 | CBD oil | - | - | - | - | [1] 51 51 💬
|
| 178 | CC-4047 | - | - | - | - | [2] 28 28, 51 💬
|
| 179 | CC-97540 | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 180 | CC312 | - | - | - | - | [5] 46 46, 49, 51, 61, 63 💬
|
| 181 | CD19 CAR T Arm | - | - | - | - | [1] 51 51 💬
|
| 182 | CD19 or CD19-BCMA CAR-T | - | - | - | - | [2] 51 51, 53 💬
|
| 183 | CD19 targeted CAR-T cells | - | - | - | - | [3] 50 50, 51, 53 💬
|
| 184 | CD19 UCAR-T cells | - | - | - | - | [5] 48 48, 49, 51, 53, 63 💬
|
| 185 | CD19- BCMA CAR-T cells | - | - | - | - | [4] 43 43, 49, 51, 53 💬
|
| 186 | CD19-BCMA CAR-T cells infusion | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 187 | CD19-CAR-DNT cells | - | - | - | - | [2] 49 49, 51 💬
|
| 188 | CD20/BCMA-directed CAR-T cells | - | - | - | - | [4] 11 11, 13, 49, 51 💬
|
| 189 | CD34 selected autologous hematopoietic cells | - | - | - | - | [1] 51 51 💬
|
| 190 | CD34+SC | - | - | - | - | [1] 51 51 💬
|
| 191 | Cetuximab | [1] Cetuximab Cetuximab | [1] Cetuximab
Cetuximab
💬
| [1] EGFR EGFR 💬
| [49] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Coronavirus disease, Cushing syndrome, Endocytosis, Endometrial cancer, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Focal adhesion, FoxO signaling pathway, Gap junction, Gastric cancer, Glioma, GnRH signaling pathway, HIF-1 signaling pathway, Hepatitis C, Hepatocellular carcinoma, Human cytomegalovirus infection, Human papillomavirus infection, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, Non-small cell lung cancer, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Virion - Hepatitis viruses 💬 | [5] 34 34, 51, 86, 89, 331 💬
|
| 192 | Chemotherapy Agents | - | - | - | - | [1] 51 51 💬
|
| 193 | Cialis | - | - | - | - | [2] 51 51, 86 💬
|
| 194 | CICLOFOSFAMIDE | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [2] 49 49, 51 💬
|
| 195 | Cilostazol | [1] Cilostazol Cilostazol | [1] Cilostazol
Cilostazol
💬
| [3] PDE3A PDE3A, PDE3B, TBXA2R 💬
| [13] Apelin signaling pathway Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Platelet activation, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 6 6, 13, 46, 48, 51, 70, 124 💬
|
| 196 | Clobetasol | [1] Clobetasol Clobetasol | [1] Clobetasol
Clobetasol
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [5] 35 35, 39, 46, 51, 162 💬
|
| 197 | Clopidogrel | [1] Clopidogrel Clopidogrel | [4] Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| [1] P2RY12 P2RY12 💬
| [3] Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | [7] 40 40, 49, 51, 62, 71, 86, 222 💬
|
| 198 | Clopidogrel treatment | [1] Clopidogrel Clopidogrel | [4] Clopidogrel bisulfate
Clopidogrel bisulfate
,
Clopidogrel
,
Clopidogrel hydrochloride
,
Clopidogrel besilate
💬
| [1] P2RY12 P2RY12 💬
| [3] Efferocytosis Efferocytosis, Neuroactive ligand signaling, Platelet activation 💬 | [1] 51 51 💬
|
| 199 | CM-101 | [1] CM-101 CM-101 | - | - | - | [2] 51 51, 94 💬
|
| 200 | CNTY-101 | - | - | - | - | [2] 49 49, 51 💬
|
| 201 | CO2 laser | - | - | - | - | [1] 51 51 💬
|
| 202 | Combination Product: Anifrolumab (blinded) | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 50 50, 51 💬
|
| 203 | Combination Product: Anifrolumab (unblinded, open label) | [1] Anifrolumab Anifrolumab | [1] Anifrolumab
Anifrolumab
💬
| [2] IFNAR1 IFNAR1, IFNAR2 💬
| [18] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 💬 | [2] 50 50, 51 💬
|
| 204 | Combination Product: Diosmin | [1] Diosmin Diosmin | [1] Diosmin
Diosmin
💬
| - | - | [1] 51 51 💬
|
| 205 | Combination Product: Efgartigimod PH20 SC | - | - | - | - | [2] 11 11, 51 💬
|
| 206 | Comirnaty | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 207 | Companion blood samples with procedure | - | - | - | - | [4] 13 13, 51, 97, 271 💬
|
| 208 | Continue IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 209 | Continue IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 210 | Continue IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 211 | Control | - | - | - | - | [8] 2 2, 6, 46, 51, 90, 97, 168, 299 💬
|
| 212 | COVID-19 mRNA Vaccine (nucleoside modified) | - | - | - | - | [3] 13 13, 46, 51 💬
|
| 213 | COVID-19 mRNA vaccine (nucleoside-modified) | - | - | - | - | [4] 13 13, 46, 51, 299 💬
|
| 214 | COVID-19 mRNA vaccine Moderna (CX-024414) | - | - | - | - | [4] 13 13, 46, 51, 299 💬
|
| 215 | COVID-19 vaccine | - | - | - | - | [4] 46 46, 49, 51, 97 💬
|
| 216 | COVID-19 Vaccine (ChAdOx1-S [recombinant]) | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 217 | COVID-19 Vaccine AstraZeneca | - | - | - | - | [2] 46 46, 51 💬
|
| 218 | COVID-19 vaccine AstraZeneca (ChAdOx1 nCoV-19) | - | - | - | - | [3] 46 46, 51, 299 💬
|
| 219 | COVID-19 Vaccine Moderna | - | - | - | - | [5] 46 46, 51, 65, 272, 299 💬
|
| 220 | Crefmirlimab | [1] Crefmirlimab Crefmirlimab | - | - | - | [4] 13 13, 25, 51, 53 💬
|
| 221 | CTX112 | - | - | - | - | [3] 51 51, 61, 63 💬
|
| 222 | Cuprimine (penicillamine) | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [1] 51 51 💬
|
| 223 | Currently available therapy in the community | - | - | - | - | [1] 51 51 💬
|
| 224 | Cutaneous iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 225 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [50] 11 11, 13, 14, 16, 19, 20, 26, 28, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 62, 63, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 223, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
| 226 | Cyclophosphamide Injection 1g | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 227 | Dabigatran | [1] Dabigatran Dabigatran | [1] Dabigatran
Dabigatran
💬
| [1] F2 F2 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [5] 51 51, 75, 85, 91, 124 💬
|
| 228 | Dabigatran etexilate | [2] Dabigatran Dabigatran, Dabigatran etexilate | [3] Dabigatran etexilate mesylate
Dabigatran etexilate mesylate
,
Dabigatran etexilate
,
Dabigatran
💬
| [1] F2 F2 💬
| [8] Complement and coagulation cascades Complement and coagulation cascades, Coronavirus disease, Neuroactive ligand-receptor interaction, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton 💬 | [2] 51 51, 75 💬
|
| 229 | Dasatinib | [1] Dasatinib Dasatinib | [2] Dasatinib
Dasatinib
,
Dasatinib
💬
| [8] ABL1 ABL1, EPHA2, FYN, KIT, LCK, PDGFRB, SRC, YES1 💬
| [79] Acute myeloid leukemia Acute myeloid leukemia, Adherens junction, Axon guidance, Bacterial invasion of epithelial cells, Bladder cancer, Breast cancer, C-type lectin receptor signaling pathway, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Choline metabolism in cancer, Cholinergic synapse, Chronic myeloid leukemia, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection, ErbB signaling pathway, Estrogen signaling pathway, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, GABAergic synapse, Gap junction, Glioma, GnRH signaling pathway, Hematopoietic cell lineage, Hepatitis B, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Inflammatory mediator regulation of TRP channels, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Mitophagy - animal, NF-kappa B signaling pathway, Natural killer cell mediated cytotoxicity, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Platelet activation, Primary immunodeficiency, Prion disease, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Sphingolipid signaling pathway, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Thyroid hormone signaling pathway, Tight junction, Tuberculosis, VEGF signaling pathway, Viral carcinogenesis, Viral myocarditis, Yersinia infection 💬 | [3] 13 13, 51, 85 💬
|
| 230 | Dengue 1,2,3,4 (attenuated) vaccine | - | - | - | - | [8] 40 40, 43, 44, 46, 48, 49, 51, 107 💬
|
| 231 | Depletion of CD3/CD19 in an autologous stem cell transplant | - | - | - | - | [2] 49 49, 51 💬
|
| 232 | Depot leuprolide acetate 3.75 mg | [2] Acetate Acetate, Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 233 | Dersimelagon | [1] Dersimelagon Dersimelagon | [1] Dersimelagon
Dersimelagon
💬
| [1] MC1R MC1R 💬
| [3] Hormone signaling Hormone signaling, Melanogenesis, Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 254 💬
|
| 234 | DI-17E6 | - | - | - | - | [1] 51 51 💬
|
| 235 | Diagnostic Test: Blood sampling | - | - | - | - | [8] 49 49, 51, 65, 74, 97, 127, 231, 299 💬
|
| 236 | Diagnostic Test: Blood Test | - | - | - | - | [5] 48 48, 51, 75, 298, 300 💬
|
| 237 | Diagnostic Test: CMRI | - | - | - | - | [2] 51 51, 86 💬
|
| 238 | Diagnostic Test: Companion diagnostic ( CDx) | - | - | - | - | [1] 51 51 💬
|
| 239 | Diagnostic Test: HRCT | - | - | - | - | [2] 51 51, 85 💬
|
| 240 | Diagnostic Test: Imaging | - | - | - | - | [3] 51 51, 94, 96 💬
|
| 241 | Diagnostic Test: Imaging, blood samples, fuctional tests and physical examination | - | - | - | - | [1] 51 51 💬
|
| 242 | Diagnostic Test: MRI | - | - | - | - | [3] 13 13, 51, 127 💬
|
| 243 | Diagnostic Test: P-MPA concentration | - | - | - | - | [1] 51 51 💬
|
| 244 | Diagnostic Test: Pulmonary function test | - | - | - | - | [1] 51 51 💬
|
| 245 | Diagnostic Test: Skin biopsies | - | - | - | - | [1] 51 51 💬
|
| 246 | Diagnostic Test: Vasculopathy assessment | - | - | - | - | [1] 51 51 💬
|
| 247 | Diethanolamine | [1] Diethanolamine Diethanolamine | [1] Diethanolamine
Diethanolamine
💬
| - | - | [2] 51 51, 86 💬
|
| 248 | DIGNA P144 CREAM | - | - | - | - | [1] 51 51 💬
|
| 249 | Diltiazem | [1] Diltiazem Diltiazem | [3] Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [4] 51 51, 58, 86, 88 💬
|
| 250 | Diltiazem Gel 2% | [1] Diltiazem Diltiazem | [3] Diltiazem hydrochloride
Diltiazem hydrochloride
,
Diltiazem malate
,
Diltiazem
💬
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
| [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 251 | DIMETHYL FUMARATE | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [5] 13 13, 20, 51, 86, 296 💬
|
| 252 | Dimethyl Fumarate (DMF) | [1] Dimethyl fumarate Dimethyl fumarate | [1] Dimethyl fumarate
Dimethyl fumarate
💬
| [1] KEAP1 KEAP1 💬
| [6] Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Parkinson disease, Pathways in cancer, Ubiquitin mediated proteolysis 💬 | [3] 13 13, 51, 86 💬
|
| 253 | Diosmin | [1] Diosmin Diosmin | [1] Diosmin
Diosmin
💬
| - | - | [4] 46 46, 51, 97, 265 💬
|
| 254 | Diphenhydramine | [1] Diphenhydramine Diphenhydramine | [4] Diphenhydramine
Diphenhydramine
,
Diphenhydramine hydrochloride
,
Diphenhydramine salicylate
,
Diphenhydramine citrate
💬
| [1] HRH1 HRH1 💬
| [4] Calcium signaling pathway Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [12] 11 11, 13, 19, 49, 51, 63, 70, 86, 96, 222, 256, 300 💬
|
| 255 | Dipyridamole | [1] Dipyridamole Dipyridamole | [1] Dipyridamole
Dipyridamole
💬
| [2] PDE4A PDE4A, PDE5A 💬
| [5] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [7] 46 46, 49, 51, 66, 96, 222, 224 💬
|
| 256 | Divalproex sodium | [1] Valproic acid Valproic acid | [3] Divalproex sodium
Divalproex sodium
,
Valproic acid
,
Valproate sodium
💬
| [7] ABAT ABAT, ALDH5A1, CACNA1G, CACNA1H, CACNA1I, GAD1, GAD2 💬
| [16] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Calcium signaling pathway, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, GnRH secretion, MAPK signaling pathway, Propanoate metabolism, Taurine and hypotaurine metabolism, Type I diabetes mellitus, Type II diabetes mellitus, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 51 51 💬
|
| 257 | Divozilimab | [1] Divozilimab Divozilimab | [1] Divozilimab
Divozilimab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [3] 13 13, 49, 51 💬
|
| 258 | Domperidone | [1] Domperidone Domperidone | [2] Domperidone
Domperidone
,
Domperidone maleate
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [5] 6 6, 13, 17, 51, 230 💬
|
| 259 | Double-Blind Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [1] 51 51 💬
|
| 260 | Drug treatment | - | - | - | - | [5] 46 46, 50, 51, 74, 271 💬
|
| 261 | Dupilumab | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [8] 51 51, 97, 98, 160, 162, 222, 300, 306 💬
|
| 262 | Dupilumab 300Mg Solution for Injection | [1] Dupilumab Dupilumab | [1] Dupilumab
Dupilumab
💬
| [1] IL4R IL4R 💬
| [8] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Inflammatory bowel disease, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [1] 51 51 💬
|
| 263 | Efzofitimod | [1] Efzofitimod Efzofitimod | [1] Efzofitimod
Efzofitimod
💬
| [2] HARS1 HARS1, HARS2 💬
| [1] Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | [2] 51 51, 84 💬
|
| 264 | Efzofitimod 270 mg | [1] Efzofitimod Efzofitimod | [1] Efzofitimod
Efzofitimod
💬
| [2] HARS1 HARS1, HARS2 💬
| [1] Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | [1] 51 51 💬
|
| 265 | Efzofitimod 450 mg | [1] Efzofitimod Efzofitimod | [1] Efzofitimod
Efzofitimod
💬
| [2] HARS1 HARS1, HARS2 💬
| [1] Aminoacyl-tRNA biosynthesis Aminoacyl-tRNA biosynthesis 💬 | [1] 51 51 💬
|
| 266 | EMA/CHMP/212874/2015 | - | - | - | - | [1] 51 51 💬
|
| 267 | EMD 525797 | - | - | - | - | [1] 51 51 💬
|
| 268 | ENDOPROST | - | - | - | - | [1] 51 51 💬
|
| 269 | ENDOPROST - 0.05 MG/0.5 ML CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA | - | - | - | - | [1] 51 51 💬
|
| 270 | ENDOPROST 0,05MG/0,5ML 1F | - | - | - | - | [1] 51 51 💬
|
| 271 | ENDOPROST 50*INFUS 1F 0,050MG/ | - | - | - | - | [1] 51 51 💬
|
| 272 | Endothelin receptor blocker | - | - | - | - | [1] 51 51 💬
|
| 273 | ENDOXAN | - | - | - | - | [6] 13 13, 28, 49, 51, 85, 162 💬
|
| 274 | Erbitux | - | - | - | - | [3] 51 51, 86, 121 💬
|
| 275 | Esbriet | - | - | - | - | [4] 46 46, 51, 85, 228 💬
|
| 276 | Ethanol | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [8] 51 51, 58, 97, 144, 214, 278, 279, 280 💬
|
| 277 | EVM18001 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 278 | EX VIVO CULTURED HUMAN MESENCHYMAL STEM CELLS | - | - | - | - | [2] 51 51, 107 💬
|
| 279 | Extracorporeal Photopheresis (ECP) | - | - | - | - | [1] 51 51 💬
|
| 280 | Fasudil | [1] Fasudil Fasudil | [2] Fasudil hydrochloride
Fasudil hydrochloride
,
Fasudil
💬
| [2] ROCK1 ROCK1, ROCK2 💬
| [25] Adherens junction Adherens junction, Axon guidance, Cadherin signaling, Chemokine signaling pathway, Focal adhesion, Human cytomegalovirus infection, Leukocyte transendothelial migration, Lipid and atherosclerosis, MicroRNAs in cancer, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Platelet activation, Proteoglycans in cancer, Regulation of actin cytoskeleton, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, TGF-beta signaling pathway, Tight junction, Vascular smooth muscle contraction, Wnt signaling pathway, Yersinia infection, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 2 2, 5, 6, 7, 51 💬
|
| 281 | Fcr blocker of autoantibodies | - | - | - | - | [1] 51 51 💬
|
| 282 | FCR001 | [1] FCR001 FCR001 | - | - | - | [1] 51 51 💬
|
| 283 | FCX-013 | [1] FCX-013 FCX-013 | - | - | - | [1] 51 51 💬
|
| 284 | Fibrogammin® 1250 | - | - | - | - | [1] 51 51 💬
|
| 285 | Fibrogammin®P, coagulation factor XIII concentrate (Human) | - | - | - | - | [1] 51 51 💬
|
| 286 | Filgrastim | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [30] 2 2, 6, 13, 25, 26, 28, 34, 35, 38, 40, 41, 42, 45, 46, 47, 49, 51, 60, 62, 63, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬
|
| 287 | Firsekibart injection | - | - | - | - | [1] 51 51 💬
|
| 288 | Fludarabine | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [30] 11 11, 13, 14, 16, 19, 28, 34, 35, 36, 44, 46, 49, 50, 51, 60, 61, 62, 63, 65, 85, 96, 107, 164, 222, 223, 283, 284, 285, 286, 326 💬
|
| 289 | Fludarabine phosphate | [1] Fludarabine Fludarabine | [2] Fludarabine phosphate
Fludarabine phosphate
,
Fludarabine
💬
| [1] RRM1 RRM1 💬
| [4] Drug metabolism - other enzymes Drug metabolism - other enzymes, Glutathione metabolism, Purine metabolism, Pyrimidine metabolism 💬 | [14] 28 28, 36, 49, 51, 60, 61, 62, 63, 65, 96, 283, 284, 285, 286 💬
|
| 290 | Fluoropyrimidine | - | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 291 | Fresolimumab | [1] Fresolimumab Fresolimumab | [1] Fresolimumab
Fresolimumab
💬
| [3] TGFB1 TGFB1, TGFB2, TGFB3 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Amoebiasis, Cell cycle, Cellular senescence, Chagas disease, Chronic myeloid leukemia, Colorectal cancer, Cytokine-cytokine receptor interaction, Diabetic cardiomyopathy, Dilated cardiomyopathy, Efferocytosis, FoxO signaling pathway, Gastric cancer, Hepatitis B, Hepatocellular carcinoma, Hippo signaling pathway, Human T-cell leukemia virus 1 infection, Hypertrophic cardiomyopathy, Inflammatory bowel disease, Integrin signaling, Intestinal immune network for IgA production, Leishmaniasis, MAPK signaling pathway, Malaria, MicroRNAs in cancer, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pancreatic cancer, Pathways in cancer, Proteoglycans in cancer, Relaxin signaling pathway, Renal cell carcinoma, Rheumatoid arthritis, TGF-beta signaling pathway, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | [3] 51 51, 222, 274 💬
|
| 292 | From August 2020 'no additional treatment' | - | - | - | - | [1] 51 51 💬
|
| 293 | FT011 | - | - | - | - | [1] 51 51 💬
|
| 294 | FT011 100 mg | - | - | - | - | [1] 51 51 💬
|
| 295 | FT011 200 mg | - | - | - | - | [1] 51 51 💬
|
| 296 | FT819 | - | - | - | - | [3] 49 49, 50, 51 💬
|
| 297 | G-CSF | [1] Filgrastim Filgrastim | [1] Filgrastim
Filgrastim
💬
| [1] CSF3R CSF3R 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | [12] 6 6, 11, 13, 51, 60, 61, 63, 65, 85, 96, 284, 285 💬
|
| 298 | G451990 | - | - | - | - | [2] 51 51, 85 💬
|
| 299 | GC012F | [1] GC012F GC012F | - | - | - | [6] 11 11, 13, 28, 46, 49, 51 💬
|
| 300 | GC012F injection | [1] GC012F GC012F | - | - | - | [4] 11 11, 28, 49, 51 💬
|
| 301 | Genetic: ALLO-329 | - | - | - | - | [2] 49 49, 51 💬
|
| 302 | Genetic: Biobanking with genetic analysis | - | - | - | - | [3] 13 13, 51, 56 💬
|
| 303 | Genetic: FCX-013 | [1] FCX-013 FCX-013 | - | - | - | [1] 51 51 💬
|
| 304 | GenSci048 | - | - | - | - | [2] 46 46, 51 💬
|
| 305 | GLIVEC | - | - | - | - | [2] 51 51, 86 💬
|
| 306 | Glivec 100 mg Filmtabletten | - | - | - | - | [2] 51 51, 86 💬
|
| 307 | GLPG1690 | - | - | - | - | [2] 51 51, 85 💬
|
| 308 | GM-CSF | - | - | - | - | [3] 51 51, 60, 229 💬
|
| 309 | Granulokine | - | - | - | - | [1] 51 51 💬
|
| 310 | GS-248 | - | - | - | - | [1] 51 51 💬
|
| 311 | GSK2330811 | - | - | - | - | [2] 51 51, 96 💬
|
| 312 | GSK2330811 Solution for Injection, 100mg/ml | - | - | - | - | [1] 51 51 💬
|
| 313 | GUSELKUMAB | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [7] 37 37, 41, 51, 96, 97, 161, 269 💬
|
| 314 | Guselkumab Dose 1 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 315 | Guselkumab Dose 2 | [1] Guselkumab Guselkumab | [1] Guselkumab
Guselkumab
💬
| [1] IL23A IL23A 💬
| [9] C-type lectin receptor signaling pathway C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis 💬 | [3] 51 51, 96, 97 💬
|
| 316 | HBI0101 CART | - | - | - | - | [5] 11 11, 13, 46, 49, 51 💬
|
| 317 | HBM7020 | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 318 | Hematopoietic Stem Cell Transplantation | - | - | - | - | [13] 11 11, 13, 14, 19, 20, 35, 46, 49, 51, 65, 96, 234, 285 💬
|
| 319 | HIDONAC*EV 1FL 5G 25ML | - | - | - | - | [1] 51 51 💬
|
| 320 | High-dose intravenous immunoglobulin (Venoglobulin-IH) | - | - | - | - | [1] 51 51 💬
|
| 321 | Hizentra | - | - | - | - | [4] 14 14, 50, 51, 65 💬
|
| 322 | HN2301 injection | - | - | - | - | [4] 11 11, 46, 49, 51 💬
|
| 323 | HN2302 Injection | - | - | - | - | [3] 11 11, 49, 51 💬
|
| 324 | HS_SW01 cells injection | - | - | - | - | [2] 51 51, 271 💬
|
| 325 | Human Anti-Transforming Growth Factor Beta-1 Monoclonal Antibody | - | - | - | - | [1] 51 51 💬
|
| 326 | Human normal immunoglobulin | - | - | - | - | [6] 13 13, 14, 50, 51, 63, 65 💬
|
| 327 | Human normal immunoglobulin for intravenous (IV) administration | - | - | - | - | [1] 51 51 💬
|
| 328 | Human normal immunoglobulin for intravenous administration | - | - | - | - | [3] 14 14, 51, 65 💬
|
| 329 | Human normal immunoglobulin for subcutaneous administration | - | - | - | - | [2] 51 51, 65 💬
|
| 330 | Hyaluronidase | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [7] 13 13, 14, 28, 51, 60, 65, 331 💬
|
| 331 | Hyaluronidase injected intradermally | [1] Hyaluronidase Hyaluronidase | [3] Hyaluronidase
Hyaluronidase
,
Hyaluronidase
,
Hyaluronidase
💬
| - | - | [1] 51 51 💬
|
| 332 | Hyperimmune caprine serum | - | - | - | - | [1] 51 51 💬
|
| 333 | Hyperoxia | - | - | - | - | [2] 51 51, 85 💬
|
| 334 | Hyperpolarized Xe129 | - | - | - | - | [5] 51 51, 85, 86, 88, 299 💬
|
| 335 | HZN-825 | - | - | - | - | [2] 51 51, 85 💬
|
| 336 | HZN-825 BID | - | - | - | - | [1] 51 51 💬
|
| 337 | HZN-825 QD | - | - | - | - | [1] 51 51 💬
|
| 338 | Ianalumab | [1] Ianalumab Ianalumab | [1] Ianalumab
Ianalumab
💬
| [1] TNFRSF13C TNFRSF13C 💬
| [5] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Human T-cell leukemia virus 1 infection, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Primary immunodeficiency 💬 | [8] 35 35, 46, 49, 51, 53, 61, 63, 95 💬
|
| 339 | Idrossiclorochina solfato | - | - | - | - | [1] 51 51 💬
|
| 340 | Ifetroban | [1] Ifetroban Ifetroban | [2] Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| [1] TBXA2R TBXA2R 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [4] 51 51, 85, 86, 113 💬
|
| 341 | IgPro10 | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 342 | IgPro20 | - | - | - | - | [4] 14 14, 50, 51, 65 💬
|
| 343 | Iguratimod | [1] Iguratimod Iguratimod | [1] Iguratimod
Iguratimod
💬
| [1] NFKB1 NFKB1 💬
| [76] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Alzheimer disease, Amoebiasis, Apoptosis, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Cadherin signaling, Cellular senescence, Chagas disease, Chemical carcinogenesis - reactive oxygen species, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Chronic myeloid leukemia, Cocaine addiction, Coronavirus disease, Cytosolic DNA-sensing pathway, Diabetic cardiomyopathy, Epithelial cell signaling in Helicobacter pylori infection, Epstein-Barr virus infection, Fluid shear stress and atherosclerosis, HIF-1 signaling pathway, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Longevity regulating pathway, MAPK signaling pathway, Measles, MicroRNAs in cancer, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Neurotrophin signaling pathway, Neutrophil extracellular trap formation, Non-alcoholic fatty liver disease, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prolactin signaling pathway, Prostate cancer, RIG-I-like receptor signaling pathway, Ras signaling pathway, Relaxin signaling pathway, Salmonella infection, Shigellosis, Small cell lung cancer, Sphingolipid signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Viral carcinogenesis, Yersinia infection, cAMP signaling pathway 💬 | [7] 46 46, 49, 51, 53, 63, 271, 300 💬
|
| 344 | IL-2 | - | - | - | - | [3] 2 2, 49, 51 💬
|
| 345 | IL6 inhibitor | - | - | - | - | [1] 51 51 💬
|
| 346 | Ilomedin | - | - | - | - | [1] 51 51 💬
|
| 347 | Iloprost | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [4] 51 51, 84, 85, 86 💬
|
| 348 | Iloprost Injection, for intravenous use | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 349 | Iloprost low dose | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 350 | ILOPROST SALE DI TROMETAMOLO | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 351 | Iloprost therapy up to 2 ng/kg x min | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 352 | ILOPROST TROMETAMOL | [1] Iloprost Iloprost | [2] Iloprost
Iloprost
,
Iloprost tromethamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 353 | Imatinib | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [12] 13 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬
|
| 354 | IMATINIB MESILATO | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 💬
|
| 355 | Imatinib Mesylate | [1] Imatinib Imatinib | [2] Imatinib mesylate
Imatinib mesylate
,
Imatinib
💬
| [3] ABL1 ABL1, KIT, PDGFRA 💬
| [34] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 13 13, 28, 34, 51, 86 💬
|
| 356 | Imiquimod | [1] Imiquimod Imiquimod | [1] Imiquimod
Imiquimod
💬
| [1] TLR7 TLR7 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 💬
|
| 357 | Imiquimod 5% Cream | [1] Imiquimod Imiquimod | [1] Imiquimod
Imiquimod
💬
| [1] TLR7 TLR7 💬
| [6] Coronavirus disease Coronavirus disease, Influenza A, Lysosome biogenesis, Measles, Neutrophil extracellular trap formation, Toll-like receptor signaling pathway 💬 | [2] 34 34, 51 💬
|
| 358 | Immune Checkpoint Inhibitors | - | - | - | - | [3] 25 25, 51, 53 💬
|
| 359 | IMMUNOGLOBULINA DI CONIGLIO ANTITIMOCITI UMANI | - | - | - | - | [1] 51 51 💬
|
| 360 | Immunoglobulina normale umana | - | - | - | - | [2] 14 14, 51 💬
|
| 361 | Immunoglobulina Normale Umana per somministrazione endovenosa | - | - | - | - | [1] 51 51 💬
|
| 362 | Immunoglobulina Normale Umana per somministrazione sottocutanea | - | - | - | - | [1] 51 51 💬
|
| 363 | IMMUNOGLOBULINA UMANA NORMALE | - | - | - | - | [4] 14 14, 51, 63, 65 💬
|
| 364 | Imnovid 1 mg hard capsules | - | - | - | - | [1] 51 51 💬
|
| 365 | INCB039110 | - | - | - | - | [3] 51 51, 97, 228 💬
|
| 366 | IND 127861 | - | - | - | - | [2] 51 51, 53 💬
|
| 367 | Indocyanine green | [2] Indocyanine green Indocyanine green, Indocyanine green acid form | [1] Indocyanine green
Indocyanine green
💬
| - | - | [9] 22 22, 41, 46, 51, 96, 235, 278, 291, 296 💬
|
| 368 | Indole | [1] Indole Indole | - | - | - | [2] 13 13, 51 💬
|
| 369 | INEBILIZUMAB | [1] Inebilizumab Inebilizumab | [1] Inebilizumab
Inebilizumab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [8] 11 11, 13, 46, 49, 51, 53, 95, 300 💬
|
| 370 | Influenza vaccine | - | - | - | - | [6] 11 11, 13, 46, 51, 84, 97 💬
|
| 371 | INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS | - | - | - | - | [1] 51 51 💬
|
| 372 | Injection of autologous stromal vascular fraction | - | - | - | - | [1] 51 51 💬
|
| 373 | Interleukin 2 | - | - | - | - | [9] 46 46, 49, 51, 56, 63, 95, 96, 97, 271 💬
|
| 374 | Intravenous Immunoglobulin | - | - | - | - | [9] 13 13, 14, 35, 38, 39, 49, 51, 63, 309 💬
|
| 375 | Intravenous Infusion | - | - | - | - | [3] 6 6, 18, 51 💬
|
| 376 | Iontophoresis of treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [1] 51 51 💬
|
| 377 | Ipilimumab | [1] Ipilimumab Ipilimumab | [1] Ipilimumab
Ipilimumab
💬
| [1] CTLA4 CTLA4 💬
| [4] Autoimmune thyroid disease Autoimmune thyroid disease, Cell adhesion molecule (CAM) interaction, Rheumatoid arthritis, T cell receptor signaling pathway 💬 | [9] 13 13, 46, 49, 50, 51, 53, 96, 97, 159 💬
|
| 378 | Itacitinib | [1] Itacitinib Itacitinib | [2] Itacitinib
Itacitinib
,
Itacitinib adipate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [4] 46 46, 51, 97, 228 💬
|
| 379 | IV Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [1] 51 51 💬
|
| 380 | IVA337 | - | - | - | - | [1] 51 51 💬
|
| 381 | Ivarmacitinib | [1] Ivarmacitinib Ivarmacitinib | [2] Ivarmacitinib
Ivarmacitinib
,
Ivarmacitinib sulfate
💬
| [1] JAK1 JAK1 💬
| [27] Coronavirus disease Coronavirus disease, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [6] 40 40, 46, 51, 56, 271, 300 💬
|
| 382 | IVIG | - | - | - | - | [8] 11 11, 13, 14, 18, 51, 63, 65, 172 💬
|
| 383 | Ixazomib | [1] Ixazomib Ixazomib | [2] Ixazomib
Ixazomib
,
Ixazomib citrate
💬
| [1] PSMB5 PSMB5 💬
| [8] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 | [4] 13 13, 16, 28, 51 💬
|
| 384 | JBT-101 | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [4] 49 49, 50, 51, 299 💬
|
| 385 | KHK4827 | - | - | - | - | [2] 37 37, 51 💬
|
| 386 | KITE-363 | - | - | - | - | [5] 11 11, 13, 14, 49, 51 💬
|
| 387 | KYV-101 | [1] KYV-101 KYV-101 | - | - | - | [5] 11 11, 13, 46, 50, 51 💬
|
| 388 | Lactobacillus | - | - | - | - | [1] 51 51 💬
|
| 389 | LANIFIBRANOR | [1] Lanifibranor Lanifibranor | [1] Lanifibranor
Lanifibranor
💬
| [3] PPARA PPARA, PPARD, PPARG 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 390 | Lenabasum | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 💬
|
| 391 | Lenabasum 20 mg | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 299 💬
|
| 392 | Lenabasum 20 mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 393 | Lenabasum 5 mg | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 51 51, 299 💬
|
| 394 | Lenabasum 5 mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 395 | Lenabasum 5mg Powder in Capsule | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 396 | Leukapheresis | - | - | - | - | [6] 49 49, 51, 85, 96, 284, 285 💬
|
| 397 | Leukopheresis | - | - | - | - | [1] 51 51 💬
|
| 398 | Leuprolide | [1] Leuprolide Leuprolide | [3] Leuprolide acetate
Leuprolide acetate
,
Leuprolide
,
Leuprolide mesylate
💬
| [1] GNRHR GNRHR 💬
| [3] GnRH signaling pathway GnRH signaling pathway, Hormone signaling, Neuroactive ligand-receptor interaction 💬 | [5] 1 1, 2, 3, 51, 76 💬
|
| 399 | Lidocaine | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [14] 6 6, 13, 22, 34, 46, 51, 70, 86, 107, 168, 226, 231, 256, 298 💬
|
| 400 | Lidocaine 2% without vessel constrictor | [1] Lidocaine Lidocaine | [3] Lidocaine
Lidocaine
,
Lidocaine hydrochloride
,
Lidocaine hydrochloride monohydrate
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [1] 51 51 💬
|
| 401 | Lipitor | - | - | - | - | [4] 51 51, 79, 96, 299 💬
|
| 402 | Liposomal bupivacaine | [1] Bupivacaine Bupivacaine | [2] Bupivacaine hydrochloride
Bupivacaine hydrochloride
,
Bupivacaine
💬
| [6] SCN1A SCN1A, SCN2A, SCN3A, SCN5A, SCN8A, SCN9A 💬
| [5] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Cadherin signaling, Dopaminergic synapse, IgSF CAM signaling, Taste transduction 💬 | [3] 51 51, 70, 96 💬
|
| 403 | Lymphodepleting Chemotherapy | - | - | - | - | [3] 49 49, 51, 300 💬
|
| 404 | MABp1 (Bermekimab) | [1] Bermekimab Bermekimab | [1] Bermekimab
Bermekimab
💬
| [1] IL1A IL1A 💬
| [21] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Alzheimer disease, Cellular senescence, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Inflammatory bowel disease, Influenza A, Leishmaniasis, MAPK signaling pathway, Measles, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 51 51 💬
|
| 405 | Mabthera | - | - | - | - | [20] 11 11, 13, 35, 43, 44, 45, 46, 50, 51, 52, 53, 61, 63, 64, 65, 83, 162, 222, 223, 271 💬
|
| 406 | Macitentan | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [5] 51 51, 85, 86, 88, 210 💬
|
| 407 | Macitentan 10 mg | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 51 51, 86, 88 💬
|
| 408 | Macitentan 10mg | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 88 💬
|
| 409 | Macitentan 3 mg | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 410 | Macitentan 3mg | [1] Macitentan Macitentan | [1] Macitentan
Macitentan
💬
| [2] EDNRA EDNRA, EDNRB 💬
| [9] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 411 | Manual toothbrush | - | - | - | - | [1] 51 51 💬
|
| 412 | Manual toothbrush and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 51 51 💬
|
| 413 | MEDI-546 | - | - | - | - | [2] 49 49, 51 💬
|
| 414 | MEDI-551 | - | - | - | - | [2] 13 13, 51 💬
|
| 415 | Mesenchymal stem cells | - | - | - | - | [16] 2 2, 6, 13, 20, 46, 49, 50, 51, 60, 96, 107, 222, 271, 274, 298, 299 💬
|
| 416 | Mesenchymal Stem Cells from Wharton ´s jellyintravenous infusion of Mesenchymal Stem Cells from Wharton ´s jelly | - | - | - | - | [1] 51 51 💬
|
| 417 | Mesenchymal Stem Cells from Wharton´s jelly | - | - | - | - | [1] 51 51 💬
|
| 418 | Mesenchymal stromal cells | - | - | - | - | [7] 36 36, 51, 96, 97, 107, 274, 284 💬
|
| 419 | Mesna | [1] Coenzyme M Coenzyme M | [1] Mesna
Mesna
💬
| - | - | [12] 11 11, 13, 16, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬
|
| 420 | Mestinon (pyridostigmine bromide) | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [1] 51 51 💬
|
| 421 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR2 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [41] 11 11, 13, 14, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 223, 240, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
| 422 | Methylprednisolon | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 51 51, 66, 223 💬
|
| 423 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [51] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 111, 127, 145, 162, 164, 211, 222, 223, 224, 271, 283, 284, 285, 296, 300 💬
|
| 424 | METHYLPREDNISOLONE ACETATE | [2] Acetate Acetate, Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 💬
|
| 425 | METHYLPREDNISOLONE SODIUM SUCCINATE | [3] Methylprednisolone Methylprednisolone, Methylprednisolone hemisuccinate, Succinic acid | [4] Methylprednisolone
Methylprednisolone
,
Methylprednisolone sodium succinate
,
Methylprednisolone acetate
,
Methylprednisolone hemisuccinate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 13 13, 46, 49, 50, 51, 211, 222 💬
|
| 426 | METOCLOPRAMIDE | [1] Metoclopramide Metoclopramide | [3] Metoclopramide
Metoclopramide
,
Metoclopramide hydrochloride
,
Metoclopramide hydrochloride
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 427 | METOCLOPRAMIDE ACCORD - 10 MG COMPRESSE 28 COMPRESSE IN BLISTER PVC/PVDC/AL | [1] Metoclopramide Metoclopramide | [3] Metoclopramide
Metoclopramide
,
Metoclopramide hydrochloride
,
Metoclopramide hydrochloride
💬
| [1] DRD2 DRD2 💬
| [10] Alcoholism Alcoholism, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 428 | METRONIDAZOLE | [1] Metronidazole Metronidazole | [2] Metronidazole
Metronidazole
,
Metronidazole hydrochloride
💬
| - | - | [7] 46 46, 51, 63, 94, 96, 97, 291 💬
|
| 429 | MHSCT | - | - | - | - | [1] 51 51 💬
|
| 430 | Microgynon | - | - | - | - | [2] 13 13, 51 💬
|
| 431 | Minibody against CD8 conjugated to desferrioxamine labeled with zirconium Zr 89 | - | - | - | - | [2] 51 51, 53 💬
|
| 432 | Mizoribine | [1] Mizoribine Mizoribine | [1] Mizoribine
Mizoribine
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 46 46, 49, 51, 53, 66, 94, 222, 224 💬
|
| 433 | MK-2225 | [1] MK-2225 MK-2225 | - | - | - | [1] 51 51 💬
|
| 434 | MK-7240/PRA023 | - | - | - | - | [1] 51 51 💬
|
| 435 | MK-7240/PRA023Pharmaceutical Form: Concentrate for solution for infusion | - | - | - | - | [1] 51 51 💬
|
| 436 | MMF | - | - | - | - | [4] 40 40, 51, 60, 222 💬
|
| 437 | MMF Immunosuppression | - | - | - | - | [1] 51 51 💬
|
| 438 | Moderna mRNA-1273 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 439 | Moderna mRNA-1273, Bivalent | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 440 | Monovalent [B.1.351] CoV2 preS dTM-AS03 | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 441 | MQX-503 | - | - | - | - | [1] 51 51 💬
|
| 442 | MSC | - | - | - | - | [5] 51 51, 60, 96, 97, 271 💬
|
| 443 | MT-7117 | - | - | - | - | [2] 51 51, 254 💬
|
| 444 | MTS109 | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 445 | MTX-474 | - | - | - | - | [1] 51 51 💬
|
| 446 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [38] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 57, 60, 61, 62, 63, 65, 66, 93, 95, 96, 118, 162, 164, 222, 223, 224, 226, 234, 283, 284, 285, 300 💬
|
| 447 | Mycophenolate mofetil (MMF) | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [8] 13 13, 49, 51, 60, 65, 66, 222, 223 💬
|
| 448 | Mycophenolate Mofetil 500mg | [1] Mycophenolate mofetil Mycophenolate mofetil | [2] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [3] 49 49, 51, 61 💬
|
| 449 | Mycophenolic acid | [1] Mycophenolic acid Mycophenolic acid | [2] Mycophenolate sodium
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH1 IMPDH1, IMPDH2 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [9] 11 11, 43, 49, 51, 60, 66, 96, 222, 223 💬
|
| 450 | N-acetylcysteine (NAC) | [1] Acetylcysteine Acetylcysteine | [1] Acetylcysteine
Acetylcysteine
💬
| - | - | [3] 34 34, 51, 299 💬
|
| 451 | Nd | - | - | - | - | [6] 2 2, 6, 13, 46, 51, 97 💬
|
| 452 | Nemolizumab | [1] Nemolizumab Nemolizumab | [1] Nemolizumab
Nemolizumab
💬
| [1] IL31RA IL31RA 💬
| [2] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬 | [1] 51 51 💬
|
| 453 | Neovasculgen | - | - | - | - | [1] 51 51 💬
|
| 454 | Nerandomilast | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [3] 2 2, 51, 85 💬
|
| 455 | Nerandomilast formulation 1 | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 456 | Nerandomilast formulation 2 | [1] Nerandomilast Nerandomilast | [1] Nerandomilast
Nerandomilast
💬
| [1] PDE4B PDE4B 💬
| [4] Morphine addiction Morphine addiction, Parathyroid hormone synthesis, secretion and action, Purine metabolism, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 457 | NEUPOGEN | - | - | - | - | [4] 13 13, 28, 51, 285 💬
|
| 458 | Nilotinib | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [5] 6 6, 8, 34, 51, 86 💬
|
| 459 | Nilotinib (Tasigna) | [1] Nilotinib Nilotinib | [1] Nilotinib
Nilotinib
💬
| [4] ABL1 ABL1, KIT, PDGFRA, PDGFRB 💬
| [35] Acute myeloid leukemia Acute myeloid leukemia, Axon guidance, Breast cancer, Cadherin signaling, Calcium signaling pathway, Cell cycle, Central carbon metabolism in cancer, Chemical carcinogenesis - reactive oxygen species, Choline metabolism in cancer, Chronic myeloid leukemia, Endocytosis, ErbB signaling pathway, Focal adhesion, Gap junction, Glioma, Hematopoietic cell lineage, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanogenesis, Melanoma, MicroRNAs in cancer, Neurotrophin signaling pathway, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Viral myocarditis 💬 | [1] 51 51 💬
|
| 460 | NINTEDANIB | [1] Nintedanib Nintedanib | [2] Nintedanib esylate
Nintedanib esylate
,
Nintedanib
💬
| [8] FGFR1 FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬
| [36] Adherens junction Adherens junction, Bladder cancer, Breast cancer, Cadherin signaling, Calcium signaling pathway, Central carbon metabolism in cancer, Choline metabolism in cancer, Endocytosis, Fluid shear stress and atherosclerosis, Focal adhesion, Gap junction, Gastric cancer, Glioma, HIF-1 signaling pathway, Human cytomegalovirus infection, Human papillomavirus infection, IgSF CAM signaling, Integrin signaling, JAK-STAT signaling pathway, MAPK signaling pathway, Melanoma, MicroRNAs in cancer, PI3K-Akt signaling pathway, Parathyroid hormone synthesis, secretion and action, Pathways in cancer, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Transcriptional misregulation in cancer, VEGF signaling pathway 💬 | [7] 51 51, 84, 85, 89, 227, 228, 331 💬
|
| 461 | Nitric Oxide | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [12] 46 46, 51, 85, 86, 88, 97, 98, 210, 251, 294, 299, 340 💬
|
| 462 | Nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [2] 51 51, 86 💬
|
| 463 | Nitroglycerin Ointment 2% | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [1] 51 51 💬
|
| 464 | Nitroglycerine gel | - | - | - | - | [1] 51 51 💬
|
| 465 | Nitroprusside | [1] Nitroprusside Nitroprusside | [1] Sodium nitroprusside
Sodium nitroprusside
💬
| - | - | [1] 51 51 💬
|
| 466 | Nivolumab | [1] Nivolumab Nivolumab | [1] Nivolumab
Nivolumab
💬
| [1] PDCD1 PDCD1 💬
| [3] Cell adhesion molecule (CAM) interaction Cell adhesion molecule (CAM) interaction, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway 💬 | [12] 13 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬
|
| 467 | NKX019 | - | - | - | - | [4] 46 46, 49, 51, 222 💬
|
| 468 | NON APPLICABILE | - | - | - | - | [3] 49 49, 51, 256 💬
|
| 469 | NON PROPIETRY, THEREFORE N/A | - | - | - | - | [1] 51 51 💬
|
| 470 | None yet | - | - | - | - | [3] 51 51, 85, 222 💬
|
| 471 | Nonmyeloablative allogeneic hematopoietic stem cell transplantation | - | - | - | - | [6] 28 28, 51, 60, 62, 65, 285 💬
|
| 472 | Ofev | - | - | - | - | [5] 51 51, 85, 89, 227, 228 💬
|
| 473 | Ofev® | - | - | - | - | [2] 51 51, 85 💬
|
| 474 | OL-108 | - | - | - | - | [2] 49 49, 51 💬
|
| 475 | OL-CD19-GDT | - | - | - | - | [2] 51 51, 53 💬
|
| 476 | Omeprazole | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [18] 6 6, 8, 13, 21, 46, 51, 67, 85, 90, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬
|
| 477 | Omeprazole 20mg | [1] Omeprazole Omeprazole | [3] Omeprazole
Omeprazole
,
Omeprazole sodium
,
Omeprazole magnesium
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [1] 51 51 💬
|
| 478 | Onabotulinumtoxin A | - | - | - | - | [2] 51 51, 226 💬
|
| 479 | Ophthalmic Emulsion | - | - | - | - | [2] 51 51, 53 💬
|
| 480 | Opsumit 10 Mg Tablet | - | - | - | - | [1] 51 51 💬
|
| 481 | Optional collection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 482 | Oral bovine type I collagen | [1] Bovine type I collagen Bovine type I collagen | - | - | - | [1] 51 51 💬
|
| 483 | Oral Ifetroban | [1] Ifetroban Ifetroban | [2] Ifetroban
Ifetroban
,
Ifetroban sodium
💬
| [1] TBXA2R TBXA2R 💬
| [3] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation 💬 | [2] 51 51, 86 💬
|
| 484 | Oral treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2] 51 51, 86 💬
|
| 485 | Order of two elements of surgical procedure | - | - | - | - | [1] 51 51 💬
|
| 486 | ORENCIA | - | - | - | - | [16] 44 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 160, 222, 223, 271, 300 💬
|
| 487 | ORM-12471 | - | - | - | - | [1] 51 51 💬
|
| 488 | ORM-12471 30mg | - | - | - | - | [1] 51 51 💬
|
| 489 | ORM-12741 | [1] ORM-12741 ORM-12741 | - | - | - | [1] 51 51 💬
|
| 490 | Other vasodilator | - | - | - | - | [1] 51 51 💬
|
| 491 | Other: anti-CD19 CAR-T cells | [1] Anti-CD19 CAR-T cells Anti-CD19 CAR-T cells | - | - | - | [1] 51 51 💬
|
| 492 | Other: Biopsy | - | - | - | - | [2] 51 51, 160 💬
|
| 493 | Other: Blood draws | - | - | - | - | [2] 49 49, 51 💬
|
| 494 | Other: Blood punction | - | - | - | - | [1] 51 51 💬
|
| 495 | Other: Blood sample | - | - | - | - | [37] 2 2, 11, 13, 34, 35, 41, 44, 46, 48, 49, 50, 51, 53, 58, 61, 63, 65, 84, 86, 96, 97, 113, 160, 162, 177, 222, 223, 227, 234, 238, 240, 256, 279, 299, 335, 340, 348 💬
|
| 496 | Other: Blood Sample Collection | - | - | - | - | [5] 6 6, 13, 51, 57, 58 💬
|
| 497 | Other: Blood Samples | - | - | - | - | [13] 3 3, 13, 46, 51, 53, 63, 85, 86, 88, 96, 98, 140, 193 💬
|
| 498 | Other: Blood sampling | - | - | - | - | [14] 6 6, 13, 19, 46, 49, 51, 53, 58, 67, 127, 222, 266, 296, 299 💬
|
| 499 | Other: Blood sampling and skin biopsy | - | - | - | - | [1] 51 51 💬
|
| 500 | Other: Blood test | - | - | - | - | [11] 10 10, 19, 46, 51, 57, 65, 66, 83, 86, 96, 113 💬
|
| 501 | Other: Bronchoalveolar samples | - | - | - | - | [1] 51 51 💬
|
| 502 | Other: Clinical data collection | - | - | - | - | [2] 49 49, 51 💬
|
| 503 | Other: Dietary recommendations | - | - | - | - | [1] 51 51 💬
|
| 504 | Other: Examination | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 505 | Other: flow cytometry | - | - | - | - | [5] 28 28, 51, 60, 65, 285 💬
|
| 506 | Other: Genetic data/DNA/RNA | - | - | - | - | [2] 49 49, 51 💬
|
| 507 | Other: Laboratory Biomarker Analysis | - | - | - | - | [22] 11 11, 13, 14, 26, 28, 34, 40, 49, 51, 60, 62, 65, 89, 96, 97, 205, 232, 283, 284, 285, 298, 331 💬
|
| 508 | Other: MMF Discontinuation | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 509 | Other: MMF maintain | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 510 | Other: MTX Discontinuation | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 511 | Other: MTX maintain | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 512 | Other: Other biological samples to biobank (skin, lung and muscle biopsies | - | - | - | - | [2] 49 49, 51 💬
|
| 513 | Other: ozone therapy | [1] Ozone Ozone | - | - | - | [1] 51 51 💬
|
| 514 | Other: Patient questionnaires | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 515 | Other: Physalis angulata ethanol extract | [1] Ethanol Ethanol | [2] Alcohol
Alcohol
,
Ethanol
💬
| - | - | [1] 51 51 💬
|
| 516 | Other: Quality-of-Life Assessment | - | - | - | - | [9] 34 34, 36, 51, 62, 65, 96, 284, 286, 298 💬
|
| 517 | Other: Questionnaire Administration | - | - | - | - | [7] 16 16, 28, 34, 51, 60, 97, 298 💬
|
| 518 | Other: Questionnaires on quality of life, pain and disability | - | - | - | - | [1] 51 51 💬
|
| 519 | Other: Rosemary essential oil | [1] Rosemary Rosemary | - | - | - | [1] 51 51 💬
|
| 520 | Other: SF-12 questionnaire | - | - | - | - | [3] 13 13, 51, 56 💬
|
| 521 | Other: Single-breath nitric oxide lung diffusing capacity measurements according to type of device in random order. | [1] Nitric Oxide Nitric Oxide | [1] Nitric oxide
Nitric oxide
💬
| - | - | [1] 51 51 💬
|
| 522 | Other: Skin biopsies | - | - | - | - | [2] 36 36, 51 💬
|
| 523 | Other: Skin swab samples | - | - | - | - | [1] 51 51 💬
|
| 524 | Other: sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [1] 51 51 💬
|
| 525 | Other: Standard treatment according to the Clinical protocols | - | - | - | - | [3] 49 49, 51, 235 💬
|
| 526 | Other: Stool samples | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 527 | Other: YTS109 cell | - | - | - | - | [4] 48 48, 49, 51, 53 💬
|
| 528 | Ozone | [1] Ozone Ozone | - | - | - | [5] 49 49, 51, 70, 71, 226 💬
|
| 529 | P144 | - | - | - | - | [1] 51 51 💬
|
| 530 | P144 cream | - | - | - | - | [1] 51 51 💬
|
| 531 | P144 Cytokine Inhibitor | - | - | - | - | [1] 51 51 💬
|
| 532 | P144 Cytokines Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 533 | P144 DIGNA CREAM | - | - | - | - | [1] 51 51 💬
|
| 534 | P144. Cytokines Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 535 | Paquinimod | [1] Paquinimod Paquinimod | - | - | - | [2] 49 49, 51 💬
|
| 536 | Part B Open-Label Extension | - | - | - | - | [1] 51 51 💬
|
| 537 | Patients will be randomized to receive EHP-101 | - | - | - | - | [1] 51 51 💬
|
| 538 | Penicillamine | [1] Penicillamine Penicillamine | [1] Penicillamine
Penicillamine
💬
| - | - | [2] 51 51, 171 💬
|
| 539 | Peripheral Blood Stem Cell Transplantation | - | - | - | - | [12] 11 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285, 286 💬
|
| 540 | Peripheral Blood Stem Cells | - | - | - | - | [2] 51 51, 65 💬
|
| 541 | Phosphodiesterase Inhibitors | - | - | - | - | [1] 51 51 💬
|
| 542 | Physiological saline | - | - | - | - | [1] 51 51 💬
|
| 543 | Pirfenidone | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [12] 13 13, 34, 40, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
|
| 544 | Pirfenidone (PFD) | [1] Pirfenidone Pirfenidone | [1] Pirfenidone
Pirfenidone
💬
| [6] CCL2 CCL2, IL10, IL1A, IL1B, IL6, TNF 💬
| [83] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, Autoimmune thyroid disease, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Chemokine signaling pathway, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Efferocytosis, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Staphylococcus aureus infection, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [2] 51 51, 85 💬
|
| 545 | PLACENTEX ® Polydeoxyribonucleotide | - | - | - | - | [1] 51 51 💬
|
| 546 | PLACENTEX ¿ Polydeoxyribonucleotide 5.625 mg/3 ml | - | - | - | - | [1] 51 51 💬
|
| 547 | PLACENTEX ¿5.625 mg/3 ml soluzione iniettabile¿ | - | - | - | - | [1] 51 51 💬
|
| 548 | Platelet Gel | - | - | - | - | [1] 51 51 💬
|
| 549 | Platinum | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 550 | Platinum Compound | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 551 | Platinum Doublet | [1] Platinum Platinum | - | - | - | [8] 13 13, 46, 49, 50, 51, 53, 96, 97 💬
|
| 552 | Plavix | - | - | - | - | [1] 51 51 💬
|
| 553 | PLERIXAFOR | [1] Plerixafor Plerixafor | [1] Plerixafor
Plerixafor
💬
| [1] CXCR4 CXCR4 💬
| [14] Axon guidance Axon guidance, Calcium signaling pathway, Chemokine signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Leukocyte transendothelial migration, Pathways in cancer, Regulation of actin cytoskeleton, Viral life cycle - HIV-1, Viral protein interaction with cytokine and cytokine receptor, Virion - Human immunodeficiency virus 💬 | [5] 20 20, 51, 65, 285, 299 💬
|
| 554 | PLETAL | - | - | - | - | [1] 51 51 💬
|
| 555 | POLYDEOXYRIBONUCLEOTIDES | - | - | - | - | [2] 51 51, 70 💬
|
| 556 | Pomalidomida | - | - | - | - | [1] 51 51 💬
|
| 557 | POMALIDOMIDE | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [6] 28 28, 34, 51, 85, 227, 331 💬
|
| 558 | Pomalidomide (CC-4047) | [1] Pomalidomide Pomalidomide | [1] Pomalidomide
Pomalidomide
💬
| [2] IL6 IL6, TNF 💬
| [78] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [1] 51 51 💬
|
| 559 | PR1 | - | - | - | - | [1] 51 51 💬
|
| 560 | PRA023 | - | - | - | - | [3] 51 51, 96, 97 💬
|
| 561 | PRA023Pharmaceutical Form: Concentrate for solution for infusion | - | - | - | - | [1] 51 51 💬
|
| 562 | Prednisolon | - | - | - | - | [11] 46 46, 50, 51, 63, 66, 95, 96, 97, 222, 223, 251 💬
|
| 563 | Prednisolona | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 564 | PREDNISOLONE | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 3 3, 11, 13, 14, 18, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 57, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 111, 113, 145, 162, 222, 223, 251, 269, 271, 296, 299, 300 💬
|
| 565 | Prednisolone 5 mg | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 46 46, 51 💬
|
| 566 | Prednisolone 5mg Gastro-resistant Tablets | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 567 | Prednisolone and taper | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 568 | Prednisoloni | - | - | - | - | [1] 51 51 💬
|
| 569 | Prednisolonum | [1] Prednisolone Prednisolone | [1] Prednisolone
Prednisolone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 570 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [58] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 127, 145, 162, 164, 205, 222, 223, 224, 228, 251, 269, 283, 284, 285, 288, 299, 300, 303, 307, 331 💬
|
| 571 | Prednizolon | - | - | - | - | [1] 51 51 💬
|
| 572 | Prednizolonas | - | - | - | - | [1] 51 51 💬
|
| 573 | PRIM-DJ2727 | - | - | - | - | [3] 6 6, 51, 97 💬
|
| 574 | PRIVIGEN | - | - | - | - | [6] 11 11, 14, 51, 63, 65, 222 💬
|
| 575 | PRIVIGEN - 100 MG/ML - SOLUZIONE PER INFUSIONE USO ENDOVENOSO FLACONCINO(VETRO) 1 FLACONCINO DA 100 ML | - | - | - | - | [1] 51 51 💬
|
| 576 | PRO-203 | - | - | - | - | [1] 51 51 💬
|
| 577 | Propylene glycol | [1] Propylene glycol Propylene glycol | [2] Propylene glycol
Propylene glycol
,
Propylene glycol diacetate
💬
| - | - | [2] 28 28, 51 💬
|
| 578 | Prostanoids | - | - | - | - | [1] 51 51 💬
|
| 579 | PRUCALOPRIDE | [1] Prucalopride Prucalopride | [2] Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [3] 13 13, 51, 96 💬
|
| 580 | PRUCALOPRIDE SUCCINATE | [1] Prucalopride Prucalopride | [2] Prucalopride
Prucalopride
,
Prucalopride succinate
💬
| [1] HTR4 HTR4 💬
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 581 | Pyridostigmine | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 582 | Pyridostigmine Bromide | [1] Pyridostigmine Pyridostigmine | [1] Pyridostigmine bromide
Pyridostigmine bromide
💬
| [1] ACHE ACHE 💬
| [3] Cholinergic synapse Cholinergic synapse, Glycerophospholipid metabolism, Neuroactive ligand signaling 💬 | [5] 3 3, 6, 11, 51, 256 💬
|
| 583 | Pyrophosphate | - | - | - | - | [1] 51 51 💬
|
| 584 | QAX576 | - | - | - | - | [4] 51 51, 85, 96, 98 💬
|
| 585 | QEL-005 | - | - | - | - | [2] 46 46, 51 💬
|
| 586 | QT-019C | - | - | - | - | [5] 11 11, 13, 49, 51, 63 💬
|
| 587 | QT-219CX | - | - | - | - | [3] 51 51, 66, 222 💬
|
| 588 | Quality-of-life assessment | - | - | - | - | [4] 28 28, 34, 51, 63 💬
|
| 589 | Rabbit | [1] Rabbit Rabbit | - | - | - | [11] 11 11, 13, 49, 51, 60, 62, 65, 96, 283, 285, 326 💬
|
| 590 | Rabeprazole | [1] Rabeprazole Rabeprazole | [2] Rabeprazole sodium
Rabeprazole sodium
,
Rabeprazole
💬
| [2] ATP4A ATP4A, ATP4B 💬
| [3] Collecting duct acid secretion Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬 | [3] 2 2, 6, 51 💬
|
| 591 | Radiation: Cone Beam Computed Tomography (CBCT) | - | - | - | - | [1] 51 51 💬
|
| 592 | Radiation: Intensity-Modulated Radiation Therapy | - | - | - | - | [1] 51 51 💬
|
| 593 | Radiation: Total Body Irradiation | - | - | - | - | [11] 19 19, 36, 49, 51, 60, 62, 65, 96, 222, 283, 284 💬
|
| 594 | Radiation: total-body irradiation | - | - | - | - | [9] 28 28, 51, 60, 62, 65, 96, 283, 284, 285 💬
|
| 595 | Rapamycin | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [13] 2 2, 15, 49, 51, 53, 60, 63, 67, 96, 158, 256, 278, 279 💬
|
| 596 | Rapcabtagene autoleucel | - | - | - | - | [5] 43 43, 44, 46, 49, 51 💬
|
| 597 | RATG | - | - | - | - | [2] 13 13, 51 💬
|
| 598 | RbATG | - | - | - | - | [2] 51 51, 96 💬
|
| 599 | RD06-04 | [1] RD06-04 RD06-04 | - | - | - | [3] 49 49, 51, 53 💬
|
| 600 | RD06-04 CART Cell Injection | [1] RD06-04 RD06-04 | - | - | - | [3] 49 49, 51, 53 💬
|
| 601 | RD06-05 CAR-T Cell Injection | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 602 | RD06-05 CART Cell Injection | - | - | - | - | [3] 13 13, 51, 223 💬
|
| 603 | Recombinant Herpes Zoster Vaccine (RZV) | - | - | - | - | [7] 46 46, 49, 50, 51, 53, 56, 107 💬
|
| 604 | Recombinant humanized anti-human monoclonal antibody directed against the IL-6R | - | - | - | - | [3] 46 46, 51, 107 💬
|
| 605 | Reduced intensity allogeneic hematopoietic stem cell transplantation | - | - | - | - | [1] 51 51 💬
|
| 606 | Reduced Intensity Allogeneic Transplant | - | - | - | - | [2] 49 49, 51 💬
|
| 607 | Relaxin | - | - | - | - | [1] 51 51 💬
|
| 608 | Relma-cel | - | - | - | - | [2] 49 49, 51 💬
|
| 609 | RESOLOR*28CPR RIV 2MG | - | - | - | - | [1] 51 51 💬
|
| 610 | Resunab, ajulemic acid, anabasum | [1] Lenabasum Lenabasum | [1] Lenabasum
Lenabasum
💬
| [1] CNR2 CNR2 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 50 50, 51, 299 💬
|
| 611 | Rheopheresis treatment | - | - | - | - | [1] 51 51 💬
|
| 612 | RIC alloBMT w PTCy in refractory SSc | - | - | - | - | [1] 51 51 💬
|
| 613 | Rilonacept | [1] Rilonacept Rilonacept | [1] Rilonacept
Rilonacept
💬
| [2] IL1A IL1A, IL1B 💬
| [44] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, African trypanosomiasis, Alcoholic liver disease, Alzheimer disease, Amoebiasis, C-type lectin receptor signaling pathway, Cellular senescence, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Cytosolic DNA-sensing pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human cytomegalovirus infection, IL-17 signaling pathway, Inflammatory bowel disease, Inflammatory mediator regulation of TRP channels, Influenza A, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Rheumatoid arthritis, Salmonella infection, Shigellosis, TNF signaling pathway, Th17 cell differentiation, Toll-like receptor signaling pathway, Tuberculosis, Type I diabetes mellitus, Yersinia infection 💬 | [5] 51 51, 84, 106, 107, 266 💬
|
| 614 | Ringer lactate | - | - | - | - | [1] 51 51 💬
|
| 615 | Riocigu | - | - | - | - | [1] 51 51 💬
|
| 616 | RIOCIGUAT | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [6] 51 51, 84, 86, 88, 225, 299 💬
|
| 617 | Riociguat (Adempas, BAY63-2521) | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [4] 51 51, 86, 88, 299 💬
|
| 618 | Riociguat coated tablet 0.5 mg | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 619 | Riociguat coated tablet 1.0 mg | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 620 | Riociguat coated tablet 1.5 mg | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 621 | Riociguat coated tablet 2.0 mg | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 622 | Riociguat coated tablet 2.5 m | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 623 | Riociguat coated tablet 2.5 mg | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 624 | Riociguat Oral Tablet | [1] Riociguat Riociguat | [1] Riociguat
Riociguat
💬
| [3] GUCY1A1 GUCY1A1, GUCY1A2, GUCY1B1 💬
| [10] Circadian entrainment Circadian entrainment, Gap junction, Long-term depression, Oxytocin signaling pathway, Platelet activation, Purine metabolism, Renin secretion, Salivary secretion, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬 | [3] 51 51, 86, 88 💬
|
| 625 | RITUXIMAB | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [54] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 48, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 88, 93, 94, 96, 97, 162, 172, 222, 223, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
| 626 | Ro 47-0203 | - | - | - | - | [4] 51 51, 85, 86, 88 💬
|
| 627 | Ro 487-7533/F10-04 | - | - | - | - | [4] 41 41, 46, 51, 107 💬
|
| 628 | RO487-7533/F10-04 | - | - | - | - | [2] 46 46, 51 💬
|
| 629 | RO7303509 | - | - | - | - | [1] 51 51 💬
|
| 630 | RoActemra | - | - | - | - | [7] 41 41, 44, 46, 51, 86, 107, 271 💬
|
| 631 | ROACTEMRA - 162 MG - SOLUZIONE INIETTABILE - USO SOTTOCUTANEO - SIRINGA PRERIEMPITA 0,9ML (VETRO) - 4 SIRINGHE PRERIEMPITE | - | - | - | - | [2] 46 46, 51 💬
|
| 632 | RoActemra 162 mg | - | - | - | - | [2] 46 46, 51 💬
|
| 633 | Rosemary | [1] Rosemary Rosemary | - | - | - | [5] 13 13, 46, 51, 97, 271 💬
|
| 634 | Rosuvastatin | [1] Rosuvastatin Rosuvastatin | [2] Rosuvastatin calcium
Rosuvastatin calcium
,
Rosuvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [16] 6 6, 18, 46, 49, 51, 56, 57, 62, 65, 67, 79, 94, 96, 97, 271, 299 💬
|
| 635 | RY_SW01 cell injection | - | - | - | - | [1] 51 51 💬
|
| 636 | Saccharomyces Boulardii Oral Tablet | - | - | - | - | [1] 51 51 💬
|
| 637 | SAR100842 | - | - | - | - | [2] 51 51, 85 💬
|
| 638 | SAR156597 | - | - | - | - | [2] 51 51, 85 💬
|
| 639 | SAR231893 | - | - | - | - | [2] 51 51, 160 💬
|
| 640 | Selexipag | [1] Selexipag Selexipag | [1] Selexipag
Selexipag
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 47 47, 51, 70, 84, 86, 88 💬
|
| 641 | Self bone marrow transplant | - | - | - | - | [1] 51 51 💬
|
| 642 | Semaglutide | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 6 6, 51, 84, 113, 299 💬
|
| 643 | Semaglutide Pen Injector | [1] Semaglutide Semaglutide | [1] Semaglutide
Semaglutide
💬
| [1] GLP1R GLP1R 💬
| [4] Hormone signaling Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 51 51, 84 💬
|
| 644 | Serial night time position splint | - | - | - | - | [1] 51 51 💬
|
| 645 | Shingrix | - | - | - | - | [6] 41 41, 46, 49, 51, 96, 97 💬
|
| 646 | Sildenafil | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [17] 6 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
|
| 647 | Sildenafil 20mg | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 648 | Sildenafil 20mg and Bosentan 62.5mg | [2] Bosentan Bosentan, Sildenafil | [4] Bosentan
Bosentan
,
Sildenafil citrate
,
Bosentan
,
Sildenafil
💬
| [3] EDNRA EDNRA, EDNRB, PDE5A 💬
| [10] Calcium signaling pathway Calcium signaling pathway, Melanogenesis, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Relaxin signaling pathway, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 649 | Sildenafil citrate | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [4] 51 51, 85, 86, 225 💬
|
| 650 | Sildenafil therapy | [1] Sildenafil Sildenafil | [2] Sildenafil citrate
Sildenafil citrate
,
Sildenafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 651 | Simvastatin | [1] Simvastatin Simvastatin | [1] Simvastatin
Simvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [22] 6 6, 13, 15, 34, 46, 49, 51, 57, 66, 79, 86, 89, 94, 158, 160, 162, 195, 223, 265, 298, 299, 310 💬
|
| 652 | Single administration of 1x10^8 viable CD4+ CAR+ Foxp3+ cells. | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 653 | Single administration of 3x10^8 viable CD4+ CAR+ Foxp3+ cells. | - | - | - | - | [3] 46 46, 51, 53 💬
|
| 654 | SINVACOR*28CPR RIV 20MG | - | - | - | - | [1] 51 51 💬
|
| 655 | Sirolimus | [1] Sirolimus Sirolimus | [1] Sirolimus
Sirolimus
💬
| [1] MTOR MTOR 💬
| [52] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Chemical carcinogenesis - receptor activation, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, Integrated stress response (ISR) signaling pathway, Integrin signaling, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, Lysosome biogenesis, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway 💬 | [46] 6 6, 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 54, 57, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 97, 98, 111, 127, 137, 157, 158, 192, 222, 223, 227, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
|
| 656 | Skin biopsy | - | - | - | - | [6] 6 6, 19, 21, 51, 84, 86 💬
|
| 657 | Skin punch biopsy | - | - | - | - | [1] 51 51 💬
|
| 658 | Sodium chloride | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [31] 2 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
|
| 659 | Sodium Chloride solution | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 11 11, 13, 51, 228 💬
|
| 660 | SODIUM CHLORIDE SOLUTION 0.9% | [1] Sodium chloride Sodium chloride | [1] Sodium chloride
Sodium chloride
💬
| - | - | [4] 51 51, 60, 288, 299 💬
|
| 661 | Sodium fluoride | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬
| - | - | [1] 51 51 💬
|
| 662 | Sodium fluoride 18F | [1] Sodium fluoride Sodium fluoride | [1] Sodium fluoride
Sodium fluoride
💬
| - | - | [1] 51 51 💬
|
| 663 | SODIUM NITROPRUSSIDE | [1] Nitroprusside Nitroprusside | [1] Sodium nitroprusside
Sodium nitroprusside
💬
| - | - | [1] 51 51 💬
|
| 664 | Sodium succinate | [1] Succinic acid Succinic acid | - | - | - | [11] 13 13, 46, 49, 50, 51, 81, 83, 95, 97, 211, 222 💬
|
| 665 | Sodium Thiosulfate | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 666 | Sodium Thiosulfate (STS) | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [3] 50 50, 51, 52 💬
|
| 667 | Sodium Thiosulfate 10% | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [2] 50 50, 51 💬
|
| 668 | Sodium Thiosulfate Injection | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [1] 51 51 💬
|
| 669 | SODIUM THIOSULFATE PENTAHYDRATE | [1] Thiosulfuric acid Thiosulfuric acid | [1] Sodium thiosulfate
Sodium thiosulfate
💬
| - | - | [2] 50 50, 51 💬
|
| 670 | Solu-Medrol | - | - | - | - | [5] 13 13, 51, 53, 97, 211 💬
|
| 671 | Solu-Medrone | - | - | - | - | [3] 51 51, 83, 162 💬
|
| 672 | Soluble Ve cadherin | - | - | - | - | [1] 51 51 💬
|
| 673 | Sonic toothbrush | - | - | - | - | [1] 51 51 💬
|
| 674 | Sonic toothbrush (Philips Sonicare) and water flosser (Philips Sonicare AirFloss) | [1] Water Water | [1] Water
Water
💬
| - | - | [1] 51 51 💬
|
| 675 | Standard Lymphodepletion regimen | - | - | - | - | [3] 11 11, 13, 51 💬
|
| 676 | Standard of Care | - | - | - | - | [18] 6 6, 13, 49, 51, 57, 58, 63, 64, 79, 84, 96, 97, 113, 171, 223, 228, 240, 291 💬
|
| 677 | Standard therapy | - | - | - | - | [5] 49 49, 51, 58, 97, 195 💬
|
| 678 | Standard Treatment group | - | - | - | - | [1] 51 51 💬
|
| 679 | Stem Cell Transplantation | - | - | - | - | [14] 13 13, 19, 20, 46, 48, 51, 60, 62, 65, 90, 125, 164, 234, 326 💬
|
| 680 | Sterile saline solution | - | - | - | - | [1] 51 51 💬
|
| 681 | Steroids | - | - | - | - | [7] 46 46, 50, 51, 63, 66, 96, 97 💬
|
| 682 | STI571 | - | - | - | - | [2] 51 51, 86 💬
|
| 683 | STK-009 | - | - | - | - | [2] 49 49, 51 💬
|
| 684 | Stromal Vascular fraction | - | - | - | - | [1] 51 51 💬
|
| 685 | STS | - | - | - | - | [2] 50 50, 51 💬
|
| 686 | Study of the gene expression profile | - | - | - | - | [1] 51 51 💬
|
| 687 | SYNCAR-001 | - | - | - | - | [2] 49 49, 51 💬
|
| 688 | T cell injection targeting CD19 chimeric antigen receptor | - | - | - | - | [7] 46 46, 49, 51, 53, 63, 93, 300 💬
|
| 689 | T cell injection targeting CD7 chimeric antigen receptor | - | - | - | - | [1] 51 51 💬
|
| 690 | Tacrolimus | [1] Tacrolimus Tacrolimus | [2] Tacrolimus
Tacrolimus
,
Tacrolimus
💬
| [5] PPP3CA PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [37] 2 2, 6, 11, 13, 36, 46, 49, 50, 51, 53, 56, 57, 60, 61, 62, 63, 65, 66, 95, 96, 97, 113, 151, 158, 164, 222, 223, 224, 226, 227, 228, 234, 283, 284, 285, 286, 299 💬
|
| 691 | Tadalafil | [1] Tadalafil Tadalafil | [1] Tadalafil
Tadalafil
💬
| [1] PDE5A PDE5A 💬
| [2] Purine metabolism Purine metabolism, cGMP-PKG signaling pathway 💬 | [8] 6 6, 51, 75, 77, 84, 86, 113, 210 💬
|
| 692 | Tadalafil and ambrisentan upfront combination therapy | [2] Ambrisentan Ambrisentan, Tadalafil | [2] Tadalafil
Tadalafil
,
Ambrisentan
💬
| [2] EDNRA EDNRA, PDE5A 💬
| [8] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Purine metabolism, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 51 51, 86 💬
|
| 693 | Tafasitamab | [1] Tafasitamab Tafasitamab | [1] Tafasitamab
Tafasitamab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 49 49, 51 💬
|
| 694 | Tafasitamab and NK cells | [1] Tafasitamab Tafasitamab | [1] Tafasitamab
Tafasitamab
💬
| [1] CD19 CD19 💬
| [5] B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Hematopoietic cell lineage, PI3K-Akt signaling pathway, Primary immunodeficiency 💬 | [2] 49 49, 51 💬
|
| 695 | TAK-007 | - | - | - | - | [1] 51 51 💬
|
| 696 | Teclistamab | [1] Teclistamab Teclistamab | [1] Teclistamab
Teclistamab
💬
| [2] CD3E CD3E, TNFRSF17 💬
| [13] Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Intestinal immune network for IgA production, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation 💬 | [5] 28 28, 49, 50, 51, 53 💬
|
| 697 | Telitacicept | [1] Telitacicept Telitacicept | - | - | - | [14] 11 11, 13, 14, 46, 48, 49, 51, 53, 63, 66, 162, 222, 223, 300 💬
|
| 698 | Temanogrel | [1] Temanogrel Temanogrel | [1] Temanogrel
Temanogrel
💬
| [1] HTR2A HTR2A 💬
| [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬 | [1] 51 51 💬
|
| 699 | TEPEZZA | - | - | - | - | [1] 51 51 💬
|
| 700 | Terguride | [1] Terguride Terguride | [1] Terguride
Terguride
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [2] 51 51, 86 💬
|
| 701 | TERGURIDE HYDROGENMALEATE | [1] Terguride Terguride | [1] Terguride
Terguride
💬
| [2] DRD2 DRD2, PRL 💬
| [14] Alcoholism Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬 | [1] 51 51 💬
|
| 702 | TGF-beta receptor type-2 extracellular domain fused to human IgG1 Fc domain | - | - | - | - | [1] 51 51 💬
|
| 703 | TGF-beta receptor type-2 fused to human IgG1 Fc domain | - | - | - | - | [1] 51 51 💬
|
| 704 | TGF-beta recettore di t | - | - | - | - | [1] 51 51 💬
|
| 705 | TGF-beta recettore di tipo II extracellulare, collegata a un dominio Fc umano modificato dell’immuno | - | - | - | - | [1] 51 51 💬
|
| 706 | Thalidomide | [1] Thalidomide Thalidomide | [1] Thalidomide
Thalidomide
💬
| [1] TNF TNF 💬
| [66] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 | [22] 2 2, 16, 20, 28, 49, 51, 53, 56, 63, 65, 84, 85, 94, 96, 97, 117, 227, 271, 280, 298, 300, 331 💬
|
| 707 | The ozone generator device (Human Pro medic, German) | [1] Ozone Ozone | - | - | - | [1] 51 51 💬
|
| 708 | Thiotepa | [1] Thiotepa Thiotepa | [1] Thiotepa
Thiotepa
💬
| - | - | [14] 13 13, 19, 20, 28, 46, 51, 60, 65, 85, 96, 107, 164, 284, 285 💬
|
| 709 | Thymoglobulin | - | - | - | - | [6] 34 34, 36, 51, 60, 96, 118 💬
|
| 710 | THYMOGLOBULINE | - | - | - | - | [5] 13 13, 36, 51, 60, 96 💬
|
| 711 | THYMOGLOBULINE - 5 MG/ML POLVERE PER CONCENTRATO PER SOLUZIONE PER INFUSIONE 1 FIALA DA 10 ML | - | - | - | - | [1] 51 51 💬
|
| 712 | TI-0032-III injection | - | - | - | - | [3] 49 49, 51, 53 💬
|
| 713 | Tibulizumab | [1] Tibulizumab Tibulizumab | [1] Tibulizumab
Tibulizumab
💬
| [2] IL17A IL17A, TNFSF13B 💬
| [8] Alcoholic liver disease Alcoholic liver disease, Cytokine-cytokine receptor interaction, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis, Th17 cell differentiation 💬 | [2] 51 51, 53 💬
|
| 714 | TM5614 | [1] TM5614 TM5614 | - | - | - | [2] 51 51, 238 💬
|
| 715 | Tocilizumab | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [26] 2 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
|
| 716 | Tocilizumab [RoActemra/Actemra] | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [4] 46 46, 51, 107, 331 💬
|
| 717 | Tocilizumab SC 162 mg/0.9 ml prefilled syringe with safety device (PFS) | [1] Tocilizumab Tocilizumab | [1] Tocilizumab
Tocilizumab
💬
| [1] IL6R IL6R 💬
| [11] Coronavirus disease Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | [1] 51 51 💬
|
| 718 | Tofacitinib | [1] Tofacitinib Tofacitinib | [2] Tofacitinib citrate
Tofacitinib citrate
,
Tofacitinib
💬
| [4] JAK1 JAK1, JAK2, JAK3, TYK2 💬
| [39] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [23] 2 2, 11, 35, 38, 39, 40, 44, 46, 49, 50, 51, 53, 56, 65, 66, 84, 96, 97, 107, 110, 162, 271, 300 💬
|
| 719 | TOP-N53 | - | - | - | - | [1] 51 51 💬
|
| 720 | TOP-N53 vehicle | - | - | - | - | [1] 51 51 💬
|
| 721 | Topical AmphiMatrix | - | - | - | - | [1] 51 51 💬
|
| 722 | Topical AmphiMatrix with nitroglycerin (MQX-503) | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [1] 51 51 💬
|
| 723 | Topical calcipotriene 0.005% ointment | - | - | - | - | [1] 51 51 💬
|
| 724 | Topical organogel with nitroglycerin | [1] Nitroglycerin Nitroglycerin | [1] Nitroglycerin
Nitroglycerin
💬
| - | - | [1] 51 51 💬
|
| 725 | Total body Irradiation | - | - | - | - | [6] 19 19, 20, 51, 60, 65, 285 💬
|
| 726 | Total-Body Irradiation | - | - | - | - | [1] 51 51 💬
|
| 727 | Tracleer | - | - | - | - | [8] 13 13, 51, 84, 85, 86, 88, 210, 211 💬
|
| 728 | TRACLEER*125MG 56CPR RIV. | - | - | - | - | [2] 51 51, 86 💬
|
| 729 | TRACLEER*56CPR RIV 125MG | - | - | - | - | [3] 51 51, 86, 88 💬
|
| 730 | Transdihydrolisuride | - | - | - | - | [2] 51 51, 86 💬
|
| 731 | Treprostinil | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [6] 51 51, 84, 85, 86, 88, 210 💬
|
| 732 | Treprostinil diethanolamine | [2] Diethanolamine Diethanolamine, Treprostinil | [4] Diethanolamine
Diethanolamine
,
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [2] 51 51, 86 💬
|
| 733 | TREPROSTINIL SODIUM | [1] Treprostinil Treprostinil | [3] Treprostinil
Treprostinil
,
Treprostinil monosodium salt
,
Treprostinil diolamine
💬
| [1] PTGIR PTGIR 💬
| [3] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Platelet activation, Vascular smooth muscle contraction 💬 | [3] 51 51, 86, 88 💬
|
| 734 | Trimebutine | [1] Trimebutine Trimebutine | [2] Trimebutine maleate
Trimebutine maleate
,
Trimebutine
💬
| [2] OPRK1 OPRK1, OPRM1 💬
| [5] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬 | [1] 51 51 💬
|
| 735 | Tulisokibart | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [5] 46 46, 51, 96, 97, 271 💬
|
| 736 | Tulisokibart CAS Number: 2648504-55-4Current Sponsor code: MK-7240/PRA023 Other descriptive name: MK-7240/PRA023Concentration unit: mg/ml milligram(s)/millilitreConcentration type: equalConcentration number: 60-Pharmaceutical form of the placebo: Solution for infusionRoute of administration of the placebo: Intravenous use | [1] Tulisokibart Tulisokibart | [1] Tulisokibart
Tulisokibart
💬
| [1] TNFSF15 TNFSF15 💬
| [1] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction 💬 | [1] 51 51 💬
|
| 737 | UCAR T-cell | - | - | - | - | [7] 11 11, 13, 14, 49, 51, 66, 222 💬
|
| 738 | UCAR-T cells | - | - | - | - | [2] 49 49, 51 💬
|
| 739 | UCMSC | - | - | - | - | [3] 51 51, 57, 94 💬
|
| 740 | Umbilical cord blood CD19-BCMA CAR-T cells infusion | - | - | - | - | [2] 51 51, 53 💬
|
| 741 | Universal allogeneic anti-CD19/BCMA CAR T-cells | - | - | - | - | [4] 11 11, 49, 51, 61 💬
|
| 742 | Urine sample | - | - | - | - | [5] 49 49, 51, 61, 63, 84 💬
|
| 743 | UT-15 SR | - | - | - | - | [1] 51 51 💬
|
| 744 | UT-15C SR | - | - | - | - | [2] 51 51, 86 💬
|
| 745 | UT-15C-SR | - | - | - | - | [2] 51 51, 86 💬
|
| 746 | UTAA91 injection | - | - | - | - | [3] 46 46, 49, 51 💬
|
| 747 | UVADEX | - | - | - | - | [3] 46 46, 51, 96 💬
|
| 748 | Vaccination with 2 doses of Shingrix vaccine | - | - | - | - | [2] 41 41, 51 💬
|
| 749 | Vaseline | - | - | - | - | [1] 51 51 💬
|
| 750 | Veledimex | [1] Veledimex Veledimex | [1] Veledimex
Veledimex
💬
| - | - | [1] 51 51 💬
|
| 751 | VIB7734 | - | - | - | - | [4] 49 49, 50, 51, 53 💬
|
| 752 | VIP | - | - | - | - | [3] 49 49, 51, 86 💬
|
| 753 | Vitamin D3 | - | - | - | - | [12] 6 6, 13, 20, 46, 49, 51, 53, 60, 65, 96, 97, 299 💬
|
| 754 | Vivomixx probiotics | - | - | - | - | [1] 51 51 💬
|
| 755 | Vixarelimab | [1] Vixarelimab Vixarelimab | [1] Vixarelimab
Vixarelimab
💬
| [1] OSMR OSMR 💬
| [3] Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, PI3K-Akt signaling pathway 💬 | [3] 51 51, 85, 97 💬
|
| 756 | Volibris | - | - | - | - | [4] 51 51, 85, 86, 88 💬
|
| 757 | Vunakizumab | [1] Vunakizumab Vunakizumab | - | - | - | [4] 40 40, 49, 51, 271 💬
|
| 758 | Water | [1] Water Water | [1] Water
Water
💬
| - | - | [36] 2 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬
|
| 759 | Withhold IS (B cell depletion therapy) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 760 | Withhold IS (MMF or MPA) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 761 | Withhold IS (MTX) | - | - | - | - | [7] 13 13, 35, 46, 49, 50, 51, 107 💬
|
| 762 | XmAb657 | - | - | - | - | [1] 51 51 💬
|
| 763 | Yellow fever vaccine | [1] Yellow fever vaccine Yellow fever vaccine | [1] Yellow fever vaccine
Yellow fever vaccine
💬
| - | - | [8] 40 40, 44, 46, 50, 51, 52, 53, 107 💬
|
| 764 | Yellow Fever vaccine (17D) | [1] Yellow fever vaccine Yellow fever vaccine | [1] Yellow fever vaccine
Yellow fever vaccine
💬
| - | - | [8] 40 40, 44, 46, 50, 51, 52, 53, 107 💬
|
| 765 | YTS109 cell | - | - | - | - | [6] 46 46, 48, 49, 51, 53, 61 💬
|
| 766 | Zamtocabtagene autoleucel | [1] Zamtocabtagene autoleucel Zamtocabtagene autoleucel | - | - | - | [2] 49 49, 51 💬
|
| 767 | ZD4054 | - | - | - | - | [1] 51 51 💬
|
| 768 | Zibotentan | [1] Zibotentan Zibotentan | [1] Zibotentan
Zibotentan
💬
| [1] EDNRA EDNRA 💬
| [7] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Pathways in cancer, Renin secretion, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 51 51 💬
|
| 769 | Ziritaxestat | [1] Ziritaxestat Ziritaxestat | [1] Ziritaxestat
Ziritaxestat
💬
| [1] ENPP2 ENPP2 💬
| [1] Ether lipid metabolism Ether lipid metabolism 💬 | [2] 51 51, 85 💬
|